cv charron 2017

41
Curriculum Vitae Martin Charron, M.D. Home Address: 2816 Bloor St West ` Unit 3 Toronto, ON M8X 1A7 Email: [email protected] Citizenship: Canada Education: 1977-79 D.E.C. College of Sherbrooke, PQ 1979-83 M.D. University of Sherbrooke, PQ Postgraduate Training and Fellowship Appointments: 1983-84 Intern in Surgery, University of Sherbrooke, PQ, Canada 1984-85 Resident I, Internal Medicine, University of Sherbrooke, PQ, Canada 1985-86 Resident II, Nuclear Medicine, University of Sherbrooke, PQ, Canada 1986-87 Resident III, Nuclear Medicine, McGill University 1987-88 Fellow, Nuclear Medicine, Harvard University 1990- Training and Accreditation in Bone Mineral Density (BMD) interpretation with 20 years’ experience. Faculty Appointments: 1990-98 Assistant Professor of Diagnostic Radiology, University of Pittsburgh School of Medicine 1998-2000 Associate Professor of Diagnostic Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 2000-05 Associate Professor of Diagnostic Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA 2005-2013 Professor of Diagnostic Imaging, University of Toronto. 2013- Professor adjoint. University of Ottawa Hospital and Administrative Appointments: 1988-89 Attending Nuclear Physician, Vancouver General Hospital 1990 Attending Nuclear Physician, Brandon General Hospital 1990-2000 Attending Nuclear Physician, University of Pittsburgh Medical Center Pittsburgh, PA and VAMC 1992-2000 Attending Nuclear Physician, Children’s Hospital of Pittsburgh, Pittsburgh, PA 1993-2000 Chief, Division of Nuclear Medicine, Department of Radiology, Children’s Hospital of Pittsburgh 1998-2000 Chief, Division of Nuclear Medicine, Tod’s Children’s Hospital, Youngstown, Ohio

Upload: martin-charron

Post on 21-Feb-2017

185 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: cv charron  2017

Curriculum Vitae

Martin Charron, M.D.

Home Address: 2816 Bloor St West

` Unit 3

Toronto, ON

M8X 1A7

Email: [email protected]

Citizenship: Canada

Education: 1977-79 D.E.C. College of Sherbrooke, PQ

1979-83 M.D. University of Sherbrooke, PQ

Postgraduate Training and Fellowship Appointments:

1983-84 Intern in Surgery, University of Sherbrooke, PQ, Canada

1984-85 Resident I, Internal Medicine, University of Sherbrooke,

PQ, Canada

1985-86 Resident II, Nuclear Medicine, University of Sherbrooke,

PQ, Canada

1986-87 Resident III, Nuclear Medicine, McGill University

1987-88 Fellow, Nuclear Medicine, Harvard University

1990- Training and Accreditation in Bone Mineral Density (BMD)

interpretation with 20 years’ experience.

Faculty Appointments:

1990-98 Assistant Professor of Diagnostic Radiology, University of

Pittsburgh School of Medicine

1998-2000 Associate Professor of Diagnostic Radiology, University of

Pittsburgh School of Medicine, Pittsburgh, PA

2000-05 Associate Professor of Diagnostic Radiology, University of

Pennsylvania School of Medicine, Philadelphia, PA

2005-2013 Professor of Diagnostic Imaging, University of Toronto.

2013- Professor adjoint. University of Ottawa

Hospital and Administrative Appointments:

1988-89 Attending Nuclear Physician, Vancouver General Hospital

1990 Attending Nuclear Physician, Brandon General Hospital

1990-2000 Attending Nuclear Physician, University of Pittsburgh Medical

Center Pittsburgh, PA and VAMC

1992-2000 Attending Nuclear Physician, Children’s Hospital of Pittsburgh,

Pittsburgh, PA

1993-2000 Chief, Division of Nuclear Medicine, Department of Radiology,

Children’s Hospital of Pittsburgh

1998-2000 Chief, Division of Nuclear Medicine, Tod’s Children’s Hospital,

Youngstown, Ohio

Page 2: cv charron  2017

2000-2004 Chief, Division Nuclear Medicine, Children’s Hospital of

Philadelphia

2005-2013 Chief, Division Nuclear Medicine, The Hospital for Sick Children

2005-2008 Head of Research for Diagnostic Imaging, The Hospital for Sick

Children

2005-2013 Senior Associate Scientist, Research Institute, The Hospital for Sick

Children

2014- Ottawa General Hospital and Brampton Nuclear Services

Specialty Certification:

1988 American Board of Nuclear Medicine Certification

1991 Fellow of the Royal College of Physician of Canada

Licensure: Pennsylvania, Ohio, Mass, NJ, Ontario, Quebec

Awards, Honors and Membership in Honorary Societies:

1998 Highlight of meeting (of many), European Association of Nuclear

Medicine Annual Meeting and World Federation of Nuclear

Medicine (Abstract #44).

1999 Image of the year, Society of Nuclear Medicine Annual

National Meeting. (Abstract #47)

2000 Ethel Brown Foerderer Fund Award (PI:Villemagne)

2000 Ethel Brown Foerderer Fund Award (PI: Dlugos)

2001 1st place Award for Outstanding Basic Science Investigation

“Journal of Nuclear Medicine”. 48th Annual Meeting Society

Nuclear Medicine, Toronto, June 23rd, 2001. JNM 2001: 42 (7)

13N. Paper # 37.

2001 Outstanding article in 2000 in Nuclear Medicine Annual 2001,

Lippincot Williams @ Wilkins p. 210 for Paper #35.

2004 Young Investigator Award Nominee Abstract #101, Annual

meeting SNM 2004.

2004-12 2nd most cited” all time” JNM manuscript # 37 (as of 8/2012)

2007 Young Investigator Award, Pediatric Council, SNM Annual

meeting 2004 , Washington, DC, Abstract #116.

2007 Certificate of Merit, Education exhibit # 3 and # 4. RSNA 93rd

Annual Meeting, Chicago..

2011 Dr. Lim, abstract # 133: PRSYM Abstract Award Winner

PATENT:

US #07468513: FAST DYNAMIC IMAGING PROTOCOL USING A MULTI-HEAD SINGLE PHOTON

EMISSION COMPUTED TOMOGRAPHY SYSTEM. Martin Charron, Girish Bal, 23 Dec 2008

Page 3: cv charron  2017

Memberships and roles in Professional and Scientific Societies, organizations

National:

CIHR

Peer Review Committee, Health Professional Awards, Fellowhips

2011-2, 2012-2013

Canadian Agencies:

CADTH Expert Advisory Panel(Canadian Agency for Drugs Technologies in

Health) 2011.

Scientific Studies

Member, Canadian STeroid-Associated Osteoporosis in the Pediatric

Population(STOPP)Consortium (a pan-Canadian, pediatric bone health working group)

International

Society of Nuclear Medicine

Past-President, Pediatric Council, 2002-2004

President, Pediatric Council 2000-2002

Treasurer-Secretary, Pediatric Council, 1999- 2001

Member, Board of Director, Pediatric Council 1998-2006

Reviewer, Pediatric Scientific Program Committee, 1997, 1999, 2000,

2006, 2014

Subchair, Scientific Program Committee, 2000, 2001, 2003, 2004, 2005

Reviewer, Scientific Program Committee- Renal, 1999, 2000

Chairman, Pediatric Scientific Program Committee, 2001

Organizer, Categorical Course Pediatric Neuroimaging, 2001

Member, House of Delegate, 2000-2002, 2002-2005

Member, Coding and reimbursement Committee, 2001

Member, Commission on Councils, 2000-2002

Member, Task Force on Governance Structure of SNM, 2001

Organizer, Advances in Pediatric Nuclear Medicine, Mid winter M. 2002

Member, Focus Group SNM WEB page 2002

Member, Ethics Committee. 2002-2003, 2003-2006

Member, Bylaws Committee. 2002-2004, 2004-2007

Member, Publication Committee. 2002-2003, 2003-2004

Member, Corporate Advisory Committee, 2003

Organizer, Categorical Pediatric Course SNM 49th Annual Meeting 2002

Member, Board of Director, New England and New York Chapter,

2002-2004, 2004-2006

Organizer, Bone imaging, CME course, 50th Annual Meeting, 2003 SNM Representatives to ACR Appropriateness Criteria Panels

Page 4: cv charron  2017

Radiological Society of North America

Member, Scientific Program Committee, Nuclear Medicine

Subcommittee, 2002, 2003, 2004, 2005

Member, Confidential Award Committee 1998-2002

American College of Radiology

ACR Appropriateness Criteria Expert Panel : 2010- 2014

Pediatric Panel

Gastrointestinal Panel

Seizure Panel

Principal investigator for ACRIN at CHOP: 2002-2004

Children Oncology Group

Member, Radiology committee 2001-

Member, Non Hodgkin Lymphoma Disease Committee 2001-

Member, ADVL0013 and ANHL0131

Member, Protocol monitoring committee 2001-2004

Member, New Approaches to Neuroblastoma Therapy Consortium 2001-2004

Society for Pediatric Radiology

Member, Nuclear Medicine Committee 2003-2005, 2—6-2008, 2008-10.

ACRIN

Member, Pediatric Radiology Committee

Canadian Association Nuclear Medicine

Member, Guidelines Task Force: 2014-

Society of Gastrointestinal Radiologists*

Society of Uroradiology*

American Gastrointestinal Association*

Institute for Clinical PET*

SCAR*

American roentgen Ray Society*

The Hasting Center; Associate Member*

American Association Advancement of Science*

Society of Fetal Urology*

American College of Nuclear Physician*

American College of Nuclear Medicine*

Association of University Radiologist*

American Medical Association*

University Saskatchewan

Invited participant, Workshop “Frontiers of Hybrid Medical Imaging Technology,

May 16, 2013.

Page 5: cv charron  2017

International Societies:

European Association of Nuclear Medicine

European Society for Pediatric Radiology

Canadian Medical Association*

AIHA Health Care Partnerships* (Member, Belarus, 1993)

CIPP VII, the 7th International Congress On Pediatric Pulmonology

Reviewer, Scientific Program Committee 2006

Local Societies:

OMA-NM Executive

The Pennsylvania Radiological Society*

*No longer an active member

Ontario Government:

PET Steering Committee, 2006-07

Reviewer. POGO Seed Funding Grant application for the 2011/2012 competition

International Scientific Committees:

Member, COG, Radiology committee 2001- Member, COG, Non Hodgkin Lymphoma Disease Committee 2001-

Member, COG, Protocol monitoring committee 2001-

Member, COG, New Approaches to Neuroblastoma Therapy Consortium 2001-

Editorial Positions:

Reviewer:

1989 Journal of the Canadian Association of Radiologists.

1994 American Journal of Rhinology.

1992-Present Journal of Nuclear Medicine

2000-Present Medical and Pediatric Oncology (Pediatric Blood &

Cancer)

2001-Present BioMed Central

2001 Canadian Institute of Health Research,Grant Application

2001-Present Neuroradiology

2002-Present Journal of Pediatric Gastroenterology and Nutrition

2003-Present Pediatric Radiology

2004-Present Journal of Urology

2006-Present Diabetes

2007-Present American Journal of Respiratory and Critical Care Medicine

2008-Present Journal of Pediatric Hematology and Oncology

2009-Present Pediatric blood and Cancer

2008- Present Journal of nuclear medicine technology

2010-Present Clinical Physiology and Functional Imaging

2010-Present Tohoku Journal of Experimental Medicine (TJEM).

Page 6: cv charron  2017

2011-2013 Grant rewierer, CHIR

2012 Grant reviewer, POGO

2012 The Journal of Rheumatology

2013 European Respiratory Society’s Handbook: Paediatric Respiratory

Medicine : Section: Isotope Imaging

2013 Cancer Management and Research

Editorial Board:

2009-2013 World journal of Radiology

2010- International Journal of Molecular Imaging

2011- ISRN Molecular Imaging

Academic Committees at Universities and affiliated Hospitals:

1992-1995 Member, Ph.D. Dissertation Committee of Nancy E. Warhafting,

Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh

1993-1994 Member, Institutional Review Board: Human Rights Committee,

Children’s Hospital of Pittsburgh; alternate member 1995.

1993-2000 Member, Radiation Drug Research Committee, University of

Pittsburgh Medical Center

1993-2000 Member, Radiation Safety Committee, University of Pittsburgh

Medical Center

1993-2000 Member Radiation Safety Committee, Children’s Hospital

of Pittsburgh

1993-2000 Member Human Use Subcommittee, University of Pittsburgh

Medical Center

1995-1999 Member, Comprehensive Doctoral Examination Committee of

Randy Wolfe, Department of Epidemiology, Graduate School of

Public Health, University of Pittsburgh

1996-2000 Member Radiation Safety Committee, University of Pittsburgh.

2000-2005 Member, Radiation Safety Committee, University of Pennsylvania

2000-2005 Member, Human Use Subcommittee, University of Pennsylvania

2000-2005 Member, Radiation Drug Research Committee, University of Pennsylvania

2000-2005 Member, Research Committee, Dept. Radiology, CHOP

2000-2003 Member, Leadership Committee, Dept. Radiology, CHOP

2001-2004 Member, Institutional Review Board. CHOP

2001-2004 Member, Radiology Technology Group

2001-2004 Chairman, Academic Affair, Dept. Radiology, CHOP

2001-2005 Member, Research Compliance Oversight Committee, CHOP

2003-2005 Member, Faculty Senate Executive Committee, University of Pennsylvania

2003-2004 Member, University Council, University of Pennsylvania.

2003-2005 Member, Medical Senate Committee, University of Pennsylvania

2003-2004 Member, Nominating Committee SEC, University of Pennsylvania

2004-2007 Member, Academic Freedom & Responsibility, University of Pennsylvania

2005-2007 Member, DI Executive Committee, HSC.

2005-2008 Chair, Radiology Scientific Review Committee, Dept of Radiology

2005 Scientific Internal Review, Pneumology, 9/05

2007- Member, Appointment committee, Research Institute, HSC.

2007 Member, Symposia Committee, Research Institute, HSC

Page 7: cv charron  2017

2008- Head of research, Nuclear Medicine residency program, U of T

2008 Member, NAIT Steering Committee, HSC

2009- Member, Search Committee, UHN, Head, Nuclear Medicine

Lectures by Invitation:

Oct. 15, 1993 Pediatric Nuclear Medicine, UPMC CME Review course, Topics in

Radiology. Pittsburgh, PA

Jan. 25, 1994 The role of Nuclear Medicine in the Investigation of Urinary Tract

Infection in Children. Grand Rounds, Mercy Hospital, Pittsburgh, PA

April 27, 1994 Pediatric Thyroid Cancer, UPMC Monthly Thyroid Cancer Conference

Jan. 26, 1995 Pediatric Renal Imaging, Society for Nuclear Medicine, Quarterly

Meeting, Pittsburgh Chapter, Technologist Section

May 16, 1996 Tc-99m HMPAO-WBC imaging. In service. Continuing education

June 6, 1996 Society of Nuclear Medicine National Meeting, Continuing Education

Course; Pediatric G.I. Imaging Update, CME Denver, Colorado

Sept. 11, 1996 Basics of Nuclear Medicine. University of Pittsburgh 4th year medical

student. September 11, 1996

March 1997 IBD and WBC-Tc99m. Leuven University

June 11, 1997 Advantages and limitation of imaging inflammatory bowel disease with

99mTc-HMPAO-WBC. Immunomedics Inc., New Jersey, Morris Plains

June 7th, 1998 Society of Nuclear Medicine 45th Annual National Meeting, Categorical

Seminar: Common Pediatric Procedures: Optimizing Technique and

Interpretation. 4.75 CME Imaging of Inflammatory Disease of the

Abdomen. Toronto, Canada

July 28, 1999 GER and Salivagram, Children’s Hospital of Pittsburgh

October 7, 1999 The role of WBC-Tc99m in the investigation of IBD, American college of

Gastroenterology Committee on guidelines, consultant for Amersham-

Nycomed Inc., Phoenix

March 15, 2000 Nuclear Medicine and the IBD Patient. Abdominal Radiology

Postgraduate Course 2000, Society of Gastrointestinal Radiologist, CME

Workshop, Kauai, HI

June 3, 2000 The role of WBC-Tc99 in the Management of Pediatric Inflammatory

Bowel Diseases. Categorical course. Pediatric Nuclear Medicine:

Advances for the new Millennium 47th Annual Meeting, Society of

Nuclear Medicine, St. Louis, Missouri

Page 8: cv charron  2017

June 10, 2000 Tc99-WBC imaging in pediatric patients. Quaterly meeting of the Society

of Nuclear Medicine-TS-Pittsburgh Charpter, Pittsburgh, PA

March 29, 2001 PediatricGI Nuclear Medicine, Society of Gastrointestinal radiology,

Abdominal Radiology Postgraduate Course, CME workdshop Scottsdale,

AZ

April 3, 2001 Mock board, Radiology resident, University of Pennsylvania

June 23, 2001 Pediatric Neurology: Building bridges to new clinical application in

pediatric Neuroimaging. Categorical course Society Nuclear Medicine

48th Annual Meeting, Toronto

Nov 2, 2001 Pediatric GI update, 13th Argentine Congress of biology and Nuclear

Medicine, Buenos Aires

Jan 30, 2002 IBD imaging with Tc99-WBC in children. Society of Nuclear Medicine of

France, 15th annual Nuclear Medicine Meeting, Serres Chevalier, France

Feb 1, 2002 The role of Nuclear medicine in children with Fever of unknow origin.

15th annual Nuclear Medicine Meeting, Serres Chevalier, France

Feb 10, 2002 Pediatric GI imaging. Mid Winter meeting of the Society of Nuclear of

North America, Florida

Feb 10, 2002 Pediatric NeuroImaging. Mid Winter meeting of the Society of Nuclear of

North America, Florida

April 16, 2002 Review in Gastrointestinal Pediatric Nuclear Medicine, Abdominal

Radiology Postgraduate Course 2002, Society of Gastrointestinal

Radiologist, CME Workshop, Orlando

June 15, 2002 Recent development in Pediatric nuclear Medicine: Is it Ethical to study

Siblings as Controls? Categorical course Society Nuclear Medicine 49th

Annual Meeting, Los Angeles, CA

Nov 1, 2002 Pediatric Nuclear Medicine, Inflammatory Bowel Disease, 16th Northeast

Regional Scientific Meeting of the New England and New York Chapters

of the Society of Nuclear Medicine Newport, Rhode Island

Jan 16, 2003 Pediatric nuclear medicine, Local course, U Penn

Jan 26, 2003 Pediatric nuclear Medicine: Is it Ethical to study Siblings as Controls?

SNM, mid winter meeting

Feb 12, 2003 Monthly conference of Philadelphia conferences series in Nuclear

Medicine, HOP

Feb 20, 2003 Update in Pediatric GastroIntestinal Nuclear Medicine, Abdominal

Radiology course, Society of Gastrointestinal Radiologists

Page 9: cv charron  2017

May 14, 2003 The new role of Nuclear Medicine in the investigation of UTI.

Philadelphia Montlhy Conference, Philadelphia, PA

Jun 21, 2003 Utility of imaging tests in the management of pediatric patients with rinary

tract infection. Categorical course. Society Nuclear Medicine 50th Annual

Meeting, New Orleans

Jun 23, 2003 Inflammatory Bowel Disease, pediatrics SNMTS CME Sessions, Society

Nuclear Medicine 50th Annual Meeting, New Orleans

July 15, 2003 Inflammatory Bowel Disease, Pediatric Grand Rounds, St-Barnabas,

Livingston, NJ

Dec 3, 2003 Refresher Course, Essential of Radiology Course, Pediatric case based

review. Radiological Society of North America, Chicago

March 5, 2004 Renal Cortical Imaging, Urology division; nurse, CHOP

June 20, 2004 Panelist, Read with the Expert session in Pediatric. Society Nuclear

Medicine 51th Annual Meeting, Philadelphia

June 22, 2004 Current Applications in Pediatric Nuclear Medicine/PET. Society Nuclear

Medicine 51th Annual Meeting, Philadelphia

June 28, 2004 Imaging of UTIs. International Congress of Radiology, Montreal

Dec 1, 2004 Refresher Course, Essential of Radiology Course, Pediatric case based

review. Radiological Society of North America, Chicago

March 2, 2005 Pediatric Genitourinary Nuclear Medicine, Society of Uroradiology annual

course, San Antonio, Texas.

April 4, 2005 Pediatric PET Imaging, American Pharmaceutical association annual

meeting, Orlando, Florida.

June 7, 2005 Pediatric PET Imaging, Society Nuclear Medicine

Dec 3, 2005 Refresher Course, Essential of Radiology Course, Pediatric case based

review. Radiological Society of North America, Chicago

June, 2006 Inflammation Imaging with PET, CME course, Society Nuclear Medicine

53th Annual Meeting, San Diego

June, 2006 PET Imaging, CME course-Technologist , Society Nuclear Medicine 53th

Annual Meeting, San Diego

July, 2006 Pulmonary Applications of PET-CT in Children. International Society of

Pediatric Pulmonology, European Respiratory Society, Montreal, Quebec

Page 10: cv charron  2017

Oct 19, 2006 Pediatric PET, SNM EGL chapter,

April 16, 2007 Pediatric PET Imaging, Society of Gastrointestinal Radiologist, CME

course, Bonita Spring, Florida.

June 5th, 2007 Pediatric Gastrointestinal Nuclear Medicine, SNM Continuing Education,

Session: Pediatric Nuclear Medicine: How I Do It, Washington , DC .

Feb 19, 2008 The Lasix Scan Revisited, Society of Uroradiology, Rancho Mirage, CA.

Feb 21, 2008 Pediatric Abdominal PET, Society of Gastrointestinal Radiology, Rancho

Mirage , CA

May 2008 PET/CT. Canadian Association of Radiologist, 71st Annual Meeting,

Ottawa.

May, 2008 PET/CT in paediatric oncology, 6th intl symposium on Pediatric nuclear

medicine, Barcelona

Dec 3, 2008 PET/CT, Grand rounds , University of London Health Centers, London,

On

Dec 14, 2008 Cardiac PET/CT, SPR Cardiovascular symposium, Toronto.

PET: A Little Review and Something New - Afternoon Session

Presentations Pediatric PET/CT 60 min.

Oct 6, 2009 4th cardiac symposium, Heart Failure and transplantation, Toronto,

Cardiac PET

25th May 2011 Pediatric PET, Pediatric Nuclear meeting 8th international symposium of

Pediatric Nuclear Medicine, Barcelona, Spain

15th October 2011 Pediatric PET, Cardiac PET, PET Imaging of Inflammation, Interesting

Cases (4 Lectures) , Institute for Advanced Medical Education, Las

Vegas, Nevada.

19th October 2011 Pediatric PET, 24th Annual Congress of the European Association of

Nuclear Medicine, Birmingham. UK.

27th March 2012 Recent advance in GI nuclear Medicine, Society of Gastrointestinal

Radiology, Scottsdale, AZ

3rd May 2012 Pediatric PET, Annual Meeting, Canadian Association of Nuclear

Medicine, Ottawa. CANM EGL-SNM 2012 Annual Conference

May 2012. PET. Annual meeting, Asian Nuclear medicine.

15th may 2013 Pediatric PET, Molecular Imaging, ½ day CME, University

Saskatchewan, Saskatoon.

Page 11: cv charron  2017

8th March 2014 Advances in Pediatric Nuclear Medicine, 59th annual meeting, SWC-

Society of Nuclear Medicine and Molecular Imaging. New Orleans. USA

23rd July 2014 NIH. National Institute of Health. Bethesda, Maryland.

October 2016 Stanford University, Department of Radiology

December 2016 UCDAVIS, Department of Radiology

Local Lectures

March 22, 2006 Nuclear Medicine-Pediatrics, PGy1-3 Toronto General Hospital

July 7, 2010 Paediatric Chemotherapy Update, PETs in Paediatric Oncology on Wed,

(morning).

Visiting Professor

Nov 14-15, 2002 The Hospital for Sick Children, Toronto, University of Toronto

Feb 23-24, 2009 Montefiore Hospital and Albert Einstein University

Organizing Roles in Scientific Meetings:

June 6, 1996 Moderator, Scientific presentation, Session 84, Bone-Clinical PET, Society of

Nuclear Medicine National Meeting. (Not in program) Denver, Colorado

June 2, 1997 Co-Moderator, Scientific Paper Session, Pediatric 1, Session 7, Society of Nuclear

Medicine National Meeting, San Antonio, Texas

June 8, 1998 Co-Moderator, Scientific Paper Session, Renal 1., Society of Nuclear Medicine

National Meeting, Toronto, Ontario

June 7, 1999 Moderator, Pediatrics I: GI/GU. Los Angeles, Society of Nuclear Medicine 46th

Annual Meeting, California

June 3, 2000 Co-Moderator, Categorical Course. Pediatric Nuclear Medicine: Advances for

the New Millennium, 47th Annual Meeting, Society of Nuclear Medicine

June 23, 2001 Organizer, Categorical Course Pediatric Neuroimaging 2001, Categorical course

Society Nuclear Medicine 48th Annual Meeting, Toronto

June 23, 2001 Moderator, Categorical Course Pediatric Neuroimaging 2001, Categorical course

Society Nuclear Medicine 48th Annual Meeting, Toronto

Page 12: cv charron  2017

June 24, 2001 Co-Organizer, CME course, Radiopharmaceutical Therapy in Pediatrics, Society

Nuclear Medicine 48th Annual Meeting, Toronto

June 24, 2001 Co-moderator, CME course, Radiopharmaceutical Therapy in Pediatrics, Society

Nuclear Medicine 48th Annual Meeting, Toronto

June 25, 2001 Moderator, Pediatrics I, Society of Nuclear Medicine 48th Annual Annual

Meeting, Toronto

Jan 27, 2002 Moderator, Pediatric Gastrointestinal Nuclear Medicine, 15th annual Nuclear

Medicine Meeting, Serres Chevalier, France

Feb 10, 2002 Organizer, Update in Pediatric Nuclear Medicine, CME course, Mid Winter

meeting of the Society of Nuclear of North America, Phoenix

Feb 10, 2002 Moderator, Update in Pediatric Nuclear Mediicne, CME course, Mid Winter

meeting of the Society of Nuclear of North America, Phoenix

June 15, 2002 Organizer, Recent development in Pediatric nuclear Medicine. Categorical course

Society Nuclear Medicine 49th Annual Meeting, Los Angeles, CA

June 15, 2002 Moderator, Recent development in Pediatric nuclear Medicine. Categorical course

Society Nuclear Medicine 49th Annual Meeting, Los Angeles, CA

Dec 3, 2002 Presiding officer, Scientific poster session nuclear Medicine Lung Liver,

Radiological Society of North America, Chicago

Dec 5, 2002 Moderator, Scientific Session “PET & Nuclear Medicine Genitourinary”.

Radiological Society of North America, Chicago

June, 2003 Organizer and Moderator, Bone imaging, CME course, Society Nuclear Medicine

50th Annual Meeting, New Orleans

June, 2003 Moderator, General Clinical Specialties Track: Pediatrics, Society Nuclear

Medicine 50th Annual Meeting, New Orleans

Dec 12, 2003 Presiding officer, Scientific Session Nuclear Medicine (Endocrine and

Miscellaneous). Radiological Society of North America, Chicago

June 22, 2004 Moderator, Pediatrics: PET I, Society of Nuclear Medicine's 51st Annual

Meeting, Philadelphia, PA

Dec 1, 2004 Presiding officer, Scientific Session Nuclear Medicine (Brain and Endocrine

Imaging). 90 th annual meeting Radiological Society of North America, Chicago

June 20, 2005 Co Moderator, Interpretation of Infrequently Performed Pediatric Nuclear

Medicine Procedures – Includes Adult Diseases Presenting in the Pediatric World

SessionType: SNM Continuing Education , Society Nuclear Medicine 52th

Annual Meeting, Toronto

Page 13: cv charron  2017

June 21, 2005 Moderator, Pediatrics: Pediatric PET II and Others , SessionType: Scientific

Paper Session , Society Nuclear Medicine 52th Annual Meeting, Toronto

June 4, 2006 Moderator, Imaging of Inflammation in Children, CME course, Society Nuclear

Medicine 53th Annual Meeting, San Diego

June 5, 2006 Moderator, PET FDG-PET (Expert Summary Session), Society Nuclear Medicine

53th Annual Meeting, San Diego

June 5, 2007 Co Moderator, SNM Continuing Education, Pediatric Nuclear Medicine: How I

Do It .

May 2, 2008 Organizer and Moderator, Half day PET/CT course (adult ). 71st annual meeting

of the Canadian Association of Radiologist, Annual Meeting, Ottawa.

June 15,2009 Chair, Meet the Author Poster Session II: Multimodality and Non-Radioactive

Molecular Imaging, General Clinical Specialties and Instrumentation & Data

Analysis Track Posters Society of Nuclear Medicine

May 26, 2011 Chairperson, Invited Lecture PET-CT and radiotherapy planning: J. Giralt

Oct 18, 2011 Chairperson, Conventional & Specialised NM: Paediatrics. European

Assosication of Nuclear Medicine Annual Meeting, Birgmigham, England

Bibliography

Research Publications, peer reviewed:

1. Charron M, Rosenthall L. Visualization of the spleen with radiophosphate in severe combined

immunodeficiency disease. Clin Nucl Med 1988; 13(5):339.

•Abstracted in Year Book Nuclear Medicine 1990, Mosby Year Book

2. Ackerman ES, Tumey SS, Charron M, English R, Deresocwicz R. Viral encephalitis: imaging with

SPECT. Clin Nucl Med 1988; 13(9):640.

3. Charron M, Mandell JB, Kolodny GM. Detection of a rare complication of appendicitis by scrotal

imaging. Clin Nucl Med 1988; 13(10):761.

4. Charron M, Ackerman ES, Kolodny GM, Rosenthall L. Focal lung uptake in patients with acquired

immunodeficiency syndrome secondary to pneumocystis carinii pneumonia. Eur J Nucl Med 1988;

14:424.

5. Schober B, Cohen P, Lyster D, Charron M, Lentle BC. Diffuse liver uptake of I-131. Letter, J Nucl

Med 1990; 31(9):1575.

Page 14: cv charron  2017

6. Tauxe WN, Mochizuki T, McCauley J, Starzl TE, Jain, Charron M. A comparison of the renal effect of

FK-506 and Cyclosporine in patients with liver transplantation. Transplant Proc 1991; 23(6):3146-3147.

7. Charron M, Levine G, Mochizuki T, Tauxe WN. Easy numbers and easier interpretation. Ann Roy Coll

Surg Letter 1991; 73(5):332.

8. Mochizuki T*, Charron M, Shah AN, Dobkin J, Tauxe WN. Hepatobiliary scintigraphy findings in acute

alcoholic hepatitis with fatty liver. Clin Nucl Med 1992; 17(3):245-246.

9. Mochizuki T*, Charron M, Shah AN, Tauxe WN. Phantom kidney: CT correlation. Ann Nucl Med

1992; 5:163-166.

10. McGinty G*, Charron ML. Bull’s eye appearance of hyperostosis frontalis interna. Clin Nucl Med

1992; 17(4):602-603.

11. Charron M, Brown M. V/Q scan can quantitative right to left shunt. Am J Respir Crit Care 1995;

151(1):253.

12. Patel K*, Charron M, Brown ML, Rogers KD, Hoberman A, Bellinger MF. Intra and interobserver

variability for a standardized rating scale for DMSA renal scans. Ped Radiol 1993; 23:506-509.

•Abstracted in Year Book of Diagnostic Radiology 1995, Mosby Year Book

13. Charron M, Orenstein SR, Bhargava S. Detection of inflammatory bowel disease in pediatric patients

with Tc99m HMPAO labeled leukocytes. J Nucl Med 1994; 35:451-455.

•Abstracted in Year Book of Diagnostic Radiology 1995, Mosby Year Book Inc.

14. Hoberman A, Wald ER, Reynolds EA, Penchansky L, Charron M. Pyuria and bacteriuria in catheterized

urine specimens obtained from young children with fever. J Pediatr 1994; 124:512-519.

•Abstracted in: Yearbook of Urology 1995

Yearbook of Family Practice 1995

Yearbook of Emergency Medicine 1995

15. Charron M, Follansbee W, Ziady GM, Kormos RL. Assessment of biventricular cardiac function in

patients with a Novacor left ventricular assist device. J Heart Lung Transplant 1994; 13:263-267.

16. Bhargava SA*, Orenstein SR, Charron M. Technetium-99m Hexamethylpropylene-amineoxime labeled

white cell scintigraphy in inflammatory bowel disease in children. J Pediatr 1994; 125:213-217.

•Abstracted in Year Book of Diagnostic Radiology, 1996, Mosby Year Book

17. Boas SR*, Charron M, Ledesma-Medina J, Noyes BE, Kurland G. Hypertrophic osteoarthropathy in a

child with follicular bronchiolitis. Clin Nuc Med 1995; 20(1):49-51.

18. Kirshen M*, Charron M, Logan TF. In-111 labeled leukocyte detection of metastatic renal cell

carcinoma. Clin Nuc Med 1995; 20(10):945-946.

Page 15: cv charron  2017

19. GlynncNW*, Meilahn EN, Charron M, Anderson SJ, Kuller LH, Cauley JA. Determinants of bone

mineral density in older men. J Bone Miner Res 1995; 10(11):1769-1777.

20. Ziccardi VB*, Charron M, Ochs MW, Braun TW. Nuclear dacryoscintigraphy: its role in oral and

maxillofacial surgery. Oral Surg Oral Med Oral Pathol Radiol Endod 1995; 80:645-649.

21. Charron M. Tailored low-dose fluoroscopic voiding cystourethrography for the reevaluation of

vesicourteteral reflux in girls. Letter. AJR 1995; 164:1027-1027.

22. Charron M, Brown M, Rowland P, Mirro J. Pain palliation with Strontium-89 in children with

neuroblastoma. Medical and Pediatric Oncology 1996; 26(6):393-396.

23. Hoberman A, Wald ER, Reynolds EA, Penchansky L, Charron M. Is urine culture necessary to rule out

urinary tract infection in young febrile children? Pediatr Infec Dis J 1996; 15(4):304-309.

24. Charron M, Orenstein SR, Bhargava SA. Detection of inflammatory bowel disease in pediatric patients

with 99mTc-HMPAO Labeled WBC. Reply. J Nucl Med 1996; 37(2):400.

25. Strom SC, Fisher RA, Rubinstein WS, Barranger JA, Towbin RB, Charron M, Mielse L, Pisarov LA,

Dorko K, Thompson MT, Reyes J. Transplantation of human hepatocytes. Transplant Proc 1997;

29(4):2103-2106.

26. Charron M, del Rosario SF, Kocoshis SA. Distribution of uptake of 99mTc-HMPAO-WBC in bowel

segments of patients with inflammatory bowel disease. Inflammatory Bowel Disease 1998; 4(2):84-88.

27. Charron M, del Rosario SF, Kocoshis SA. Comparison of the sensitivity of early versus delayed

imaging with 99mTc-HMPAO-WBC in children with inflammatory bowel disease. Clin Nucl Med 1998;

23(10):649-653.

28. Charron M Bone pain palliation in children with SR-89, letter. Med Pediatr Oncol 1998; 30(3):199-

200.

29. Charron M, del Rosario SF, Kocoshis SA. Use of Technetium tagged white blood cells in patients with

Crohn’s disease and ulcerative colitis: Is differential diagnosis possible? Ped Radiol 1998; 28(11):871-

877.

30. Charron M, del Rosario SF, Kocoshis SA, Putnam PE, DiLorenzo C, Orenstein SR. Characterization of

late abdominal accumulation of 99m Tc-HMPAO-WBC in a large population of normal children. Nucl

Med Commun 1998; 19(8):193-198.

31. Charron M, del Rosario SF, Kocoshis SA. Assessment of terminal ileal and colonic inflammation in

children with Crohn’s disease with Tc-99m labeled WBC. Acta Paeditrica 1999; 88(2):193-198.

•Abstracted in Year Book of Radiology, 2000, Mosby-Year Book

•Abstracted in “Literature Alert” of Current Gastroenterology Reports 1999; 1(3):183.

32. Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M, Kearney DH, Reynolds EA,

Ruley J, Janosky JE. Oral versus intravenous therapy for urinary tract infections in young febrile

children. Pediatric 1999; 104(1)79-86.

Page 16: cv charron  2017

33. Charron M, del Rosario SF, Kocoshis SA. Pediatric inflammatory bowel disease: Assessment with

scintigraphy with 99mTc-White Blood Cells. Radiology 1999; 212(2):507-551.

•Abstracted in Year Book of Nuclear Medicine, 2000, Mosby-Year Book

34. Charron M, DiLorenzo C, Kocoshis SA. Leukocytes-Tc99m scintigraphy in Crohn’s disease of the small

bowel and stomach. Pediatric Surgery International 1999; 15(7):500-504.

35. Charron M, DiLorenzo C, Kocoshis SA. Are 99Tc leukocyte scintigraphy and SBFT studies useful in

children suspected of having inflammatory bowel disease? Am J Gastroenterol, 2000; 95(5):1208-1212.

Outstanding article in 2000 in Nuclear Medicine Annual 2001, LW@W p. 210

36. Bohnen NI, Charron M, Reyes J, Rubenstein W, Strom S, Swanson D, Towbin R. Indium-111 labeled

hepatocytes for determination of biodistribution of transplanted hepatocytes via portal vein infusion.

Clin Nucl Med 2000; 25(6):447-450.

37. Beyer*T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R.

A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41(8) 1369-1379.

1st place Award for Outstanding Basic Science Investigation for 2000. Editioral board Journal Nuc

Med 2001: 42 (7) 13N

2nd most cited JNM article of all time (as of …)

38. Wolf RL, Cauley JA, Baker C, Ferrell RE, Charron M, Caggiula AW, Salamone LM, Heaney RP, Kuller

LH. Factors associated with calcium absorption efficiency in pre-and perimenopausal women. Am J

Clin Nutr 2000; 72:466-71.

39. Charron M, Townsend DW, Beyer T, Bohnen N, Kinahan PE, Meltzer CC, Dachille M, Jerin J, Nutt R.

Whole-body FDG PET and CT imaging in malignancies using a combined PET/CT scanner. Clin Nucl

Med, 2000; 25(11) 905-910.

First clinical manuscript on PET/CT

40. Meltzer CC, Luketich JF, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachile MA,

Townsend DW. Comparative analysis of whole-body PET and CT imaging for staging of esophageal

cancer. Clin Nucl Med 2000; 25(11): 882-888.

41. Charron M, Kocoshis S, Del Rosario F, Goyal A, Orenstein S. Poor imaging technique produces poor

results; again! J Peds 2000; Dec;137(6):888 Letter.

42. Bohnen N, Charron M. Isolated Lower Extremity I-131 bone marrow uptake in a runner. Clin Nucl Med.

2001; 26(2) 163.

43. Finder JD, Yellon R, Charron M. Successful management of chronic salivary aspiration with intra-

tracheal constant positive airway pressure. Pediatrics 2001; Jun;107(6):1343-5.

44. Eidelman BH, Pulipaka U, Wiley C, Charron M., Bohnen NI. Abnormal Cerebral Blood Flow Findings

In Transplant Patients With Post-Transplant Apraxia Of Speech" Transplant Proc 2001;

Jun;33(4):2563-5.

Page 17: cv charron  2017

45. Charron M, Di Lorenzo C, Kocoshis SA, Hickeson MP, Orenstein SR, Goyal A, Kahn S, Collins L.

99mTc Antigranulocyte Monoclonal Antibody Imaging for the Detection and Assessment of

Inflammatory Bowel Disease Newly Diagnosed by Colonoscopy in Children. Pediatric Radiology 2001;

31:796-800.

46. Charron M, Di Lorenzo C, Kocoshis SA. CT and 99mTc- WBC Vs Colonoscopy In The Evaluation Of

Inflammation And Complications Of Inflammatory Bowel Diseases. Journal of Gastroenterology 2002;

37 (1):23-28.

47. Hoberman A, Charron M, Hickey RW, Baskin M, Kearney DH, Wald ER. The Value of Imaging

Studies Following a First-Diagnosed Urinary Tract Infection (UTI) in Young Children. N Engl J Med

2003; 348(3):195-202.

Editorial: Stapleton, FB. Imaging Studies for Childhood Urinary Infections. N Engl J Med 2003;

348(3):251-252.

Abstracted in: Radiology. 231(2):607

48. Hahn K, Charron M, Shulkin BL. Role of MR imaging and iodine 123 MIBG scintigraphy in staging of

Pediatric Neuroblastoma (letter). Radiology 2003; 227(3):908.

49. Accorsi R, Morowitz M, Charron M, Maris J. Pinhole Imaging of 131I-Metaiodobenzylguanidine

(131I-MIBG) in an Animal Model of Neuroblastoma. Pediatr Radio 2003; 33:688-692.

50. Alberini JL *, Charron M, von Allmen D, Markovitch J, Hurh Peter. Temporal Evolution of the

Intensity of inflammatory Bowel Disease in Children: Correlation of A Semi-Quantitative Analysis of

Bowel Uptake in White Blood Cells Scintigraphy with Biological Parameters. Annals of Nuclear

Medicine and Sciences, 2003, 16(1): 1-7.

http://www.ceps.com.tw/ec/ecjnlissuelist.aspx?jnlcattype=o&jnltype=440&newIssueiid=7357

51. Charron M. Inflammatory Bowel Disease Activity Assessment With Biological Markers And 99mTC-

Wbc Scintigraphy: Are There Different Trends In Ileitis Versus Colitis? J Nucl Med. 2003; 44(10):

1586-1591.

52. Kang TI*, Trophy T, Hickeson M, Heyman S, Evans AE, Charron M, Maris JM.Targeted radiotherapy

with low dose 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma. J

Pediatr Hematol Oncol. 2003; Oct;25(10):769-773.

53. Charron M. Temporal Correlation of the Erythrocytes Sedimentation Rate with 99mTc-WBC Uptake in

Children with Inflammatory Bowel Disease. Clin Nucl Medi 2003; 28(11):905-907.

54. Charron M, Lentle BC. Is it really this simple? Letter to the Editor. Pediatric Radiology 2003; 33(11):

811-814.

55. Bai C*, Kinahan P, Brasse D, Comtat C, Townsend D, Meltzer CC, Villemagne V, Charron M. Defrise

M. An analytic study of the effects of Attenuation Correction on Tumor Detection in Whole Body PET

Oncology Imaing. J Nucl Med. 2003; 44 (11): 1855-1861.

56. Hickeson M*, Charron M, Maris JM, Brophy P, Kang TI, Zhuang H, Khan J, Nevrotski T.

Biodistribution Of Post-Therapeutic Versus Diagnostic 131-I-MIBG Scans In Children With

Neuroblastoma. Pediatr Blood Cancer 2004; 42:268-274.

Page 18: cv charron  2017

57. Bhargava P*, Kumar R, Zhuang H, Charron M., Alavi A. Catheter Related Focal FDG activity on

Whole Body PET Imaging. Clin Nucl Med 2004; 29 (4):238-243.

58. Bhargava P*, Zhuang H, Kumar R, Charron M, Alavi A. Iatrogenic Artifacts on Whole body

F18-FDG PET Imaging . Clin Nucl Med 2004; 29 (7):429-439.

59. Khan J*, Charron M , Hickeson M , Accorsi R, Qureshi S. Canning D. Supranormal Renal Function In

Unilateral Hydronephrotic Kidney Can Be Avoided. Clin Nucl Med 2004; 29 (7):410-414.

60. DuBois SG, Messina J, Maris JM, Huberty J, Glidden DV, Veatch J, Charron M, Hawkins R , Matthay

KK. Hematologic Toxicity of High Dose 131I-Metaiodobenzylguanidine Therapy for Advanced

Neuroblastoma. J Clin Oncol 2005; 22:2452-2460.

61. Bhargava P, Charron M, Beauchemin D. Asymmetric Lower Limb Muscle Activity on a Gallium Scan.

Clin Nucl Med 2005; 30(5):367-368.

62. Messina JA, Cheng SC, Franc BL, Charron M, Shulkin B, To B, Maris JM, Yanik G, Hawkins RA,

Matthay KK. Evaluation of Semi-Quantitative Scoring System for Metaiodobenzylguanidine (mIBG)

Scans in Patients with Relapsed Neuroblastoma, Running Title: mIBG scoring in relapsed

neuroblastoma. Pediatr Blood Cancer 2006; 47(7):865-874.

63. Hoe FM, Charron M, Moshang T Jr. Use of the recombinant human TSH stimulated thyroglobulin level

and diagnostic whole body scan in children with differentiated thyroid carcinoma. J Pediatr Endocrinol

Metab 2006; 19(1):25-30.

64. Chotipanich C. Hickeson, M. Khan, J. Beauchemin, D. Canning, D. Charron, M. Correlation of the

ERPF with the extraction fraction values of technetium-99m mercaptoacetyltriglycine. J Med Assoc

Thai. J Med Assoc Thai. 2006 Sep;89(9):1479-86.

65. Chotipanich C, Rubin, J.Lin, J. Charron, M. Clinical follow-up of children with low differential

function on diuretic renogram J Med Assoc Thai 2007. 90 (4): 754-61.

66. Coates AL, Green M, Leung K, Louca E, Tservistas M, Chan J, Ribeiro N, Charron M. The challenges

of quantitative measurement of lung deposition using 99mTc-DTPA from delivery systems with very

different delivery times. J Aerosol Med 2007. 20(3): 320-330.

67. Noli K, Solomon M, Charron M, Golding F, Ling SC. The Prevalence of Hepatopulmonary

Syndrome in Children. Pediatrics. 2008;112:e498-e500.

68. Ribeiro N. Green, M. Charron, M.Assessment of Multiple Intravenous Infusion Pump Systems Infusing

Into a Single Site. J Nucl Med Technol 2008; 36(2): 88-90

69. Coates A. L. Green, M. Leung, K. Chan, J. Ribeiro, N. Louca, E. Ratjen, F. Charron, M. Tservistas, M.

Keller, M. Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic

fibrosis: A pilot project. Pediatr Pulmonol. 2008 ; 43(8) 753-759

70. Newman B., Grosse-Whormann L., Charron M, Yoo SJ. "A Pitfall f Radioisotope Quantification of

Qp/Qs In A Patient with Severe Postoperative Pulmonary Venous Obstruction" . Clinical Nuclear

Medicine 2008; 33(8): 521-4

Page 19: cv charron  2017

71. The importance of obtaining conjugate views on renographic evaluation of large hydronephrotic

kidneys: an in vitro and ex vivo analysis. J Urol. 2008 Oct;180(4):1559-65.

72. Rachmiel M., M. Charron, et al. "Evidence-based review of treatment and follow up of pediatric patients

with differentiated thyroid carcinoma." J Pediatr Endocrinol Metab 19(12): 1377-93.

73. Halton J., I. Gaboury, et al. (2009). "Advanced vertebral fracture among newly diagnosed children with

acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric

Population (STOPP) research program." J Bone Miner Res 24(7): 1326-34. Member of the consortium.

74. Zheng J., Allen, C. Serra, S. Vines, D. Charron, M. Jaffray, D. A.Liposome Contrast Agent for CT-

based Detection and Localization of Neoplastic and Inflammatory Lesions in Rabbits: Validation with

FDG-PET and Histology" Contrast Media and Molecular Imaging 2010; 5 (3): 147-154.

75. Huber AM, I. Gaboury D. A, Cabral, . Lang 1 A. Ni, D. Stephure, S. Taback, P. Dent, J. Ellsworth, C.

Leblanc, C. Saint-Cyr, R. Scuccimarri, J. Hay, B. Lentle, M. Matzinger, N. Shenouda, D. Moher, F.

Rauch, K. Siminoski, L. M. Ward, And The Canadian Steroid-Associated Osteoporosis In The Pediatric

Population (Stopp) CONSORTIUM Skeletal Findings in Children Recently Initiating Glucocorticoids

for the Treatment of Nephrotic Syndrome: Results of the Canadian STeroid-associated Osteoporosis in

the Pediatric Population (STOPP) Research Program ; Arthritis Care & Research Vol. 62, No. 4, April

2010, pp 516–526. Member of the Consortium

76. Coates AL, Denk O, Leung K, Ribeiro N, Chan J, Green M, Martin S, Charron M, Edwardes M, Keller

M. Higher Tobramycin Concentration And Vibrating Mesh Technology Can Shorten Antibiotic

Treatment Time In Cystic Fibrosis. Pediatric Pulmonology 2010: 46(4) : 401-8

77. A Comparison of Amount and Speed of Deposition Between the PARI LC STAR((R)) Jet Nebulizer and

an Investigational eFlow((R)) Nebulizer. J Aerosol Med Pulm Drug Deliv. 2011 : 24(3): 157-63

78. Lim L, Benseler SM, Tyrrell PN, Charron M, Harvey E, Hebert D, Sillverman ED: Low bone

mineral density is present in newly diagnosed paediatric systemic lupus erythematosus patients.Ann

Rheum Dis. 2011 Nov;70(11):1991-4

79. Parida L, Morrisson GT, Shammas A, Hossain AKM, McCarville MB, Charron M, Rao BN, Shulkin

BL. Role of lymphoscintigraphy and sentinel lymph node biopsy in the management of pediatric

melanoma and sarcoma Pediatric Surgery International 2012: Volume 28: (6): 571-578

80. Siminoski, Kerry; Lee, Kwok-Choy; Jen, Ho; Warshawski, Robert; Matzinger, Mary-Ann; Shenouda,

Nazih; Charron, Martin; Coblentz, Craig; Dubois, Josee; Kloiber, Reinhard; Nadel, Helen; O'Brien,

Kathy; Reed, Martin; Sparrow, Keith; Webber, Colin; Lentle, Brian; Ward, Leanne. Anatomical

Distribution of Vertebral Fractures: Comparison of Pediatric and Adult Spines" . Osteoporos Int. 2012

Jul;23(7):1999-2008.

81. Amin R, Charron M, Grinblat L, Shammas A, Grasemann H, Ratjen F. Positron Emission Tomography-

Computed Tomography (PET/CT) to assess changes in airway inflammation in pediatric patients with

cystic fibrosis. Radiology 2012: 264(3): 868-875

Page 20: cv charron  2017

82. Lim, L. S. Benseler, S. M. Tyrrell, P. N. Harvey, E. Herbert, D.Charron, M. Silverman, E. D.Predicting

Longitudinal Trajectories Of Bone Mineral Density In Pediatric Systemic Lupus Erythematosus

Patients. Annals of the Rheumatic Diseases. March 2012

83. Costantini, D. L., Vali, R., Chan, J., McQuattie, S., Charron, M. "Dual time point FDG PET/CT for the

evaluation of pediatric tumors", American Journal of Roentgenology 2013: 200(2): 408-13.

84. Widjaja, E. Shammas, A. Vali, R. Otsubo, H. Ochi, A. Snead, O. C. Go, Charron M. FDG-PET and

magnetoencephalography in pre-surgical workup of children with localization-related non-lesional

epilepsy. Epilepsia. 2013 Feb 8. doi: 10.1111/epi.12114

85. El Zein M, Vali R, Charron M, Manson D, Perlman K, Shammas A. Neuroendocrine Tumor in Liver

with Positive ACTH receptor: A case report. In press Journal of Pediatric Hematology and Oncology

2013.

86. McCarville MB, Billups C, Wu J, Kaufman R, Kaste S, Coleman J, Sharp S, Nadel H, Charron M,

Lederman H, Don S, Shochat S, Daw NC, Shulkin B. The Role of PET-CT in Assessing Pulmonary

Nodules in Children with Solid Malignancies. AJR Am J Roentgenol. 2013 Dec;201(6):W900-5

87. Coates AL, Leung K, Chan J, Ribeiro N, Charron M, Schuh S. Respiratory system deposition with a

novel aerosol delivery system in spontaneously breathing healthy adults. Respir Care. 2013

Dec;58(12):2087-92

88. Reza Vali, Marianna Rachmiel, Jill Hamilton, Mohamad El Zein, Jonathan Wasserman, Danny L.

Costantini, Martin Charron, Alan Daneman . The role of ultrasound in the follow-up of children with

differentiated thyroid cancer. Pediatr Radiol. 2015 Jul;45(7):1039-45. doi: 10.1007/s00247-014-3261-0.

Epub 2014 Dec 19.

89. Jaremko JL, Siminoski K, Firth GB, Matzinger MA, Shenouda N, Konji VN, Roth J, Sbrocchi AM,

Reed MH, O'Brien MK, Nadel H, McKillop S, Kloiber R, Dubois J, Coblentz C, Charron M, Ward LM;

Common normal variants of pediatric vertebral development that mimic fractures: a pictorial review

from a national longitudinal bone health study. Pediatr Radiol. 2015 Apr;45(4):593-605. doi:

10.1007/s00247-014-3210-y. Epub 2015 Apr 1.

90. Wehbi E, Salle A, Kanaroglou N, Lorenzo A, Bagli D, Koyle M, Billimek J, Vali R, Charron M, Pippi

Salle JL. Measurement of Differential Renal Function by Scintigraphy in Hydronephrotic Kidneys:

Importance of Conjugate Views for Accurate Evaluation. J Urol. 2016 Feb;195(2):471-5

91. Costantini DL, Vali R, McQuattie S, Chan J, Punnett A, Weitzman S, Shammas A, Charron M.

A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma. International. Journal of Molecular

Imaging, 2016;6045894

92. Shammas A, Doria AS, Amirabadi A, Gahunia H, Jong R, Charron M, Moineddin R, Metser UPilot

study on 18 F-FDG PET/CT for detection of inflammatory changes in blood-induced knee arthropathy

in a rabbit model.Hemophilia. Haemophilia. 2016 Oct 20. doi: 10.1111/hae.13090.

93. reza vali, MD. Alaa Bakari; eman Marie; Mahnaz Kousha; martin charron Original article for other

authors entitled "FDG uptake in cervical lymph nodes in children without head and neck cancer".

Submitted 2016

Page 21: cv charron  2017

94. Influence of chronic multifocal osteomyelitis on densitometry… Submitted 2016.

95. Mucociliary clearance . Submitted 2016.

Multicenter-Consortium: Steroid-associated Osteoporosis in the Pediatric Population (STOPP)

43 Manuscripts

42 Abstracts

84 presentations

Contributions to peer-reviewed clinical research publications, participation cited but not by authorship:

Ph.D. thesis, Thomas Beyer, March 2000.

Research Publications, non-peer reviewed:

1. Charron M, Orenstein SR, Bhargava SA. Detection of inflammatory bowel diseaes in pediatric

patients with Technetium-99m-HMPAO-labeled leukocytes. Medical Imaging International. ISSN

1068-1779, Formerly MedicalCare International. N. 11-12, Globetech publication, October 1994, p.

16-17.

2. Charron M. Evaluation of inflammatory bowel diseases with radiolabeled leulocytes. Medical

Imaging International 2001. 11 (2) 3-4 p.18-20.

Books

Charron M. (Ed). Pediatric Positron Emission Tomography Imaging. Springer Verlag. New York,

2006. ISBN 10:387-28836-8

Abstracts:

1. Stewart MA, Fung AY, Charron M, Rexworthy C. Application of “Ad Hoc” Dipyridamole Thallium

scans: Clinical Nuclear Medicine, v.14, n9s, p 21, 1989. (Presented at the Society of Nuclear Medicine

Meetings, Western Regional Meeting, October 1989)

Page 22: cv charron  2017

2. Patel K*, Charron M, Brown ML, Rogers KD, Hoberman A, Bellinger MF. Intra and interobserver

variability for a standardized rating scale for DMSA renal scans. Journal of Nuclear Medicine

1995;33(5)922. (Presented at the Society of Nuc Med, Los Angeles, June 1992)

3. Milko DL, Charron M. The value of radionuclide angiogram and blood pool imaging in evaluation of

bone disease in adults. Journal of Nuclear Medicine Technology 1992;20(2)120. (Presented at the

Society of Nuc Med, June 1992)

4. Charron M, Follansbee W, Ziady GM, Kormos RL. Assessment of biventricular cardiac function in

patients with a Novacor left ventricular assist device. European Journal of Nuclear Medicine

1992;19(8)665. (Presented at the European Society of Nuc Med, Lisbon, Portugal, August 23-26, 1992)

5. Shanker R*, Charron M, Mochizuki T, Tauxe WN. Detection of bile leaks in liver transplant infarcts by

hepatobiliary scintigraphy. Journal of Nuclear Medicine 1992;33(5)997. (Presented at the Society of

Nuc Med, LA., June 1992)

6. Shanker R*, Charron M, Klein HA, Milko D. A novel substraction algorithm for parathyroid

scintigraphy. Journal of Nuclear Medicine 1992;33(5)996. (Presented at the Society of Nuc Med, June

1992)

7. Shah A, Shanker R, Bellinger M, Charron M. Functional assessment by diuretic renogram pre and post

pyeloplasty in children. Journal of Nuclear Medicine 1992;33(5)977. (Presented at the Society of Nuc

Med, June 1992)

8. Warhaftig N*, Cauley J, Kuller L, Rohay J, Charron M. Hip and spine bone mineral density in men:

association with age and obesity. Journal of Bone Mineral Research 1992;7(Suppl. 1)5320. (Presented

at the American Society for Bone and Mineral Research, Minneapolis, MN, October 3, 1992)

9. Hoberman A, Wald E, Charron M, Ellis D, Penchansky L, Reynolds E. Oral vs IV therapy of

pyelonephritis in children 1-24 months. Pediatric Research Vol 1993;33(4)p II:118A. (Presented at the

American Pediatric Society Annual Meeting, Washington, DC, May 6, 1993)

10. Charron M, Orenstein SR, Bhargava S. Detection of inflammatory bowel disease in pediatric patients

with 99mTc-HMPAO-labeled leukocytes. Abstracted in the Syllabus of Society of Pediatric Radiology,

May 1993. (Presented at the Society of Pediatric Radiology, Seattle Washington, May 1993)

11. Bhargava SA*, Orenstein SR, Charron M. Advantages of the novel 99mTc HMPAO-labeled WBC scan

in evaluating localization & intensity of IBD in children: Correlation with resected specimens & with

clinical data. American Journal of Gastroenterology;88(9)1559. (Presented at the Pediatric Midwest Gut

Club, August 7, 1993, Cincinnati)

12. Charron M, Patel K, Hoberman A, Bellinger M. A new technique to improve detection of

Vesicoureteral reflux with Radionuclide VCUG (Amelioration technique de la cystographie isotopique),

Medicine Nucleaire 1993;17(7/8)351. (Presented at the XXXII International Nuclear Medicine Meeting

(French), Fort de FRANCE, November 20-22)

13. Charron M, Patel K, Hoberman, Bellinger M. New technique to improve detection of vesicoureteral

reflux with Radionuclide VCUG. Abstracted in the syllabus of the Society of Pediatric Radiology, April

1994. (Presented at the Society Ped. Radiology, Colorado Springs, CO, April 27, 1994)

Page 23: cv charron  2017

14. Hoberman A, Wald ER, Reynolds, Charron M, Penchansky L. Cost-effective screening for urinary tract

infection (UTI) in young children with fever. Archives of Pediatric and Adolescent Medicine

1994;148:46. (Presented at the American Pediatric Society, Society of Pediatric Research, Ambulatory

Pediatric Association, May 2, 1994)

15. Sotereanos NG*, Sotareanos DG, Rubash HE, Berger RA, Schoedel KE, Charron M, Norrell MK, Yas

KM. Vascularized orthotopic osteochondral transplantation of the canine proximal femur. Transaction

of the Orthopedic Research Society, 19(2)550, 1994. (Presented at the 40th Annual Meeting,

Orthopaedic Research Society, February 21-24, 1994, New Orleans, Louisiana.)

16. Hoberman A, Wald ER, Charron M, Reynolds EA. Benefit of imaging studies for managing febrile

children with urinary tract infection (UTI). Archives of Pediatric Adolescent Medicine 1994;148:31.

(Presented at the American Pediatric Society, Society of Pediatric Research, Ambulatory Pediatric

Association, May 2, 1994.)

17. Charron M, Fisher NA, Kocoshis S, Neigut D, Swanson D, Tauxe WN. Detection of protein losing

enteropathy. European Journal of Nuclear Medicine 1994;21(8)756. (Presented at the European Society

of Nuclear Medicine. Dusseldorf, Germany, August 20-24, 1994, selected as a highlight of meeting.)

18. Hoberman A, Wald ER, Reynolds EA, Charron M, Penchansky L. Oral vs intravenous therapy for acute

pyelonephritis in children. Pediatric Research 1994;35(4)Part II:143A. (Presented at the American

Pediatric Society, Society of Pediatric Research, Ambulatory Pediatric Association, May 2, 1994)

19. Torok F*, Charron M, Foley TP. The perchlorate washout test revisited. European Journal of Nuclear

Medicine 1994;21 S225. (Presented at the World Federation of Nuclear Medicine & Biology 6th World

Congress Sydney, Australia, October 23-28, 1994)

20. Charron M, Rowland P, Mirro J, Brown M. Pain palliation with Strontium-89 in children with bone

tumor. Edited by: I. Roca, first edition, Second European Symposium on Pediatric Nuclear Medicine,

March 1995, B-10781-95, p. 197. (Presented at the Second European Symposium on Pediatric Nuclear

Medicine, Barcelona, Spain, March 1995)

21. Hoberman A, Hickey R, Wald E, Reynold E, Charron M, Scherzer DJ, Martin JM. Pyuria as a marker of

infection vs colonization of the urinary tract in febrile children 1-24 months. Pediatric Research

1995;37:138 A. (Presented at the American Pediatric Society, Society for Pediatric Research, 1995.)

22. Brown M, Charron M, Shah AN, Lister J, Kirkwood JM, Stalteri MF. Tumor imaging with Gallium-67:

a cost effective strategy. Radiology 1995;1979P)385. (Presented at the Radiological Society North

America, Chicago, November 1995)

23. Hoberman A, Charron M, Wald ER, Reynolds EA. Imaging studies in the follow-up of children with

first diagnosed urinary tract infection. Pediatric Research 1996;39(4)part II:133 A. (Presented at the

Pediatric Research issue. APS-SPR, Washington,DC, May 6-10, 1996.)

24. Hoberman A, Wald ER, Reynolds EA, Charron M. Oral vs Intravenous therapy for acute pyelonephritis

in children 1-24 months. Pediatric Research 1996;39(4)Part II:134A. (Presented at the Pediatric

Research issue. APS-SPR, Washington,DC, May 6-10, 1996)

25. Lucey D, Charron M. Quantification of HMPAO-Tc-99m labeled white blood cells data in diagnosis of

inflammatory bowel disease. Journal of Nuclear Medicine Technology, V24(2) June 1996;160.

Page 24: cv charron  2017

(Presented at the Society of Nuclear Medicine annual meeting, Technologist section, Denver, CO, June

3-6, 1996)

26. Wolf RL, Gregg EW, Charron M, Salamone L, Black DM, Epstein RS, Cauley JA. Fractional calcium

absorption vs dietary intake of calcium: relationship to bone quality in pre and perimenopausal women.

Journal of Bone and Mineral Research, 1996;11(S11)S4641. (Presented at the American Society for

Bone and Mineral Research, June 1996.)

27. Reyes J, Rubinstein WS, Mieles L, Strom SC, Towbin RB, Trucco M, Charron M, Barranger JA. The

use of cultured hepatocyte infusion via the portal vein for the treatment of ornithine transcarbamoylase

deficiency by transplantation of enzymatically competent abo/rh-matched cell. Hepatology. 24(4 PART

2). 1996. 308A. (Presented at the International Congress of Human Genetics. Rio de Janiero, May 25-

30, 1996)

28. Charron M, del Rosario SF, Kocoshis SA, Putnam PE, DiLorenzo C, Orenstein SR. Assessment of

bowel inflammation in children with Crohn’s disease; colonoscopy versus Technetium-labeled white

blood cells. Gastroenterology, April 1997;112(4):A947. (Presented at the Society of Nuclear Medicine.

June 1997. San Antonio, TX)

29. Charron M, del Rosario SF, Kocoshis SA, Putnam PE, DiLorenzo C, Orenstein SR. Differentiation

between continuous and discontinuous colitis with white blood cells labeled with technetium in children.

Gastrointestinal Endoscopy. 1997;45(4):AB106.

30. Charron M, del Rosario JF, Kocoshis SA. Distribution of uptake of Tc-99mHMPAO-white blood cell in

bowel segments of patients with inflammatory bowel disease. Journal of Nuclear Medicine

1997;38(5)253. (Presented at the Society of Nuclear Medicine. June 1997. San Antonio, TX)

31. Charron M, del Rosario JF, Kocoshis SA, Putnam PE, DiLorenzo C, Orenstein SR. Characterization of

late abdominal accumulation of Tc-99m-HMPAO-white blood cell in a large population of normal

children. Journal of Nuclear Medicine 1997;38(5)290. (Presented at the Society of Nuclear Medicine.

June 1997. San Antonio, TX)

32. Charron M, del Rosario JF, Kocoshis SA, Putnam PE, DiLorenzo C, Orenstein Sr. Assessment of bowel

inflammation with Tc-99m-HMPAO-white blood cells vs colonoscopy and biopsy. Journal of Nuclear

Medicine 1997;38(5)24. (Presented at the Society of Nuclear Medicine. June 1997. San Antonio, TX)

33. Charron M, del Rosario JF, Kocoshis SA, Putnam PE, Di Lorenzo C. Orenstein Sr. Colonoscopy versus

Technetium-labeled white blood cells in patients with Crohn’s disease. European Journal of Nuclear

Medicine 1997;24(8)1022. (Presented at the European Society of Nuclear Medicine Annual Meeting,

Glasgow, Scotland,8/25/1997)

34. Wolf RL, Cauley JA, Danielson ME, Zmuda JM, Charron M, Heany RP. Calcium absorption does not

differ between older African American and Caucasian American women. Journal of Bone and Mineral

Research 1997;12(1)S149. (Presented at the American Society for bone and Mineral research .

Cincinati, OH. 9/1997)

35. Charron M, del Rosario JF, Kocoshis SA. Comparison of the sensitivity of early versus delayed

imaging with 99mTc-HMPAO-WBC in children with inflammatory bowel disease. European Journal of

Nuclear Medicine 1997;24(8)1004. (Presented at the European Society of Nuclear Medicine annual

meeting, Glasgow, Scotland,8/25/1997)

Page 25: cv charron  2017

36. Charron M, del Rosario JF, Kocoshis SA, Putnam PE, DiLorenzo C, Orenstein SR. Sensitivity and

specificity of Technetium-labeled white blood cells in pediatric inflammatory bowel disease. European

Journal of Nuclear Medicine 1997;24(8)878. (Presented at the European Society of Nuclear Medicine

Annual Meeting, Glasgow, Scotland, 8/25/1997)

37. Cauley J, Wolf R, Salamone L, Charron M. Influence of the human menstrual cycle on calcium (ca)

absorption. American Journal of Epidemiology 1997;145(11)S58. (Presented at the Society for Bone

and Mineral Research, Cincinatti, OH 9/97.)

38. MG Kiaffas, A Korang, GJ Boyle, SG Pophal, K Lawrence, M Charron, SA Miller, BP Griffith, SA

Webber. Medium and long-term renal function after pediatric heart transplantation with cyclosporine or

tacrolimus based immunosuppression. Third Loma Linda International Conference on Pediatric Heart

and Lung Transplantation. Rancho Mirage, California. January 22-24, 1997.

39. Danielson ME, Cauley JA, Zmuda JM, Ngo D, Charron M. Fractional calcium absorption in mothers

and daughters. Journal of Bone and Mineral Research 1997;12(1)S554. (Presented at the American

Society for Bone and Mineral Research, Edmonton, Canada, 6/12-14/97)

40. Ranger NT, Murtha P, Collins L, Charron M, Brown M. A network-integrated functional data storage

solution for nuclear medicine applications. Exhibit, Journal of Nuclear Medicine 1997;38(5)306.

(Presented at the Society of Nuclear Medicine, 1997)

41. Charron M, del Rosario JF, Kocoshis SA. Three dimensional imaging with WBC-Tc99m in the

assessment of inflammation in children with IBD. American Journal of Roentgenlogy

1998;170(4)S190. (Presented at the ARRS San Francisco 1998)

42. Charron M, Dockery Se, del Rosario JF, Kocoshis SA. Accuracy and limitations of 3D imaging of

inflammatory bowel disease with WBC-Tc99m. Pediatric Radiology 1998;28(8)651. (Presented at the

Society for pediatric radiology annual meeting. Long paper. May 7th, 1998, Tucson , Arizona)

43. Ohwada T, Ishii T, Bueno J, Sigurdsson L, Charron M, Kocoshis S, Mazariegos G, Reyes J. Gastric

emptying in children with extreme short gut syndrome. Gastroenterology1998;114A:812-

813.(Presented at the American Gastroenterological association. New orleans. May 16-22 1998)

44. Meltzer CC, Luketich JD, Charron M, Strollo D, Meehan M, Urso GK, Townsend DW. Whole-body

PET imaging for esophageal cancer staging: University of Pittsburgh experience. Radiology,

1998;209:291. (Presented at the Radiological Society of North America 1998, Chicago)

45. Charron M, del Rosario JF, Kocoshis SA. 3D imaging of inflammatory bowel disease with WBC-Tc-99.

European Journal of Nuclear Medicine 1998;24(8)8954. (Presented at the European society of nuclear

medicine and world federation of nuclear medicien. Berlin. Sept 3 1998)

•Abstracted in highlights of meeting. European Journal of Nuclear Medicine 25;12:1682(os469)

46. Putnam PE, Charron M. Continuous overnight gastroesophageal reflux scintigraphy. Gastroenterology,

1999;116(4-2)A573. (Presented at the Digestive Disease Week, 1999)

Page 26: cv charron  2017

47. Charron M, DiLorenzo C, Kocoshis SA. Is 99mTc-WBC scintigraphy useful in children suspected of

having inflammatory bowel disease? Journal of Nuclear Medicine, 1999; 40(5)50. (Presented at the

Society of Nuclear Medicine 1999, Los Angeles)

48. Townsend DW, Beyer T, Kinahan PE, Charron M, Meltzer CC, Dachille MA, Jerin J, Brun T, Roddy R,

Nutt R, Byars LG. Fusion imaging for whole-body oncology with a combined PET and CT scanner.

Journal of Nuclear Medicine, 1999; 40(5)148. (Presented at the Society of Nuclear Medicine 1999, Los

Angeles)

• Image of the year. Society of Nuclear Medicine Annual Meeting (46 and 47).

• Abstracted in Eur J Nucl Med 2000; 27(2) 256

49. Charron M, Beyer T, Kinahan PE, Meltzer CC, Dachille MA, Townsend DW. Whole-body FDG PET

and CT imaging of malignancies using a combined PET/CT scanner. Journal of Nuclear Medicine

1999;40(5)256. (Presented at the Society of Nuclear Medicine 1999, Los Angeles)

• Abstracted in Eur J Nucl Med 2000; 27(2) 257

50. Charron M, Bohnen NI, Reyes J, Rubenstein W, Strom S, Swanson D, Towbin RB. Indium-111 labeled

hepatocytes for determination of biodistribution of transplanted human hepatocytes via portal vein

infusion. Journal of Nuclear Medicine, 1999; 40(5)189. (Presented at the Society of Nuclear Medicine

1999, Los Angeles)

51. Wolf RL*, Zuma JM, Charron M, RP Heaney, JA Cauley. Calcium absorption efficiency in

community-dwelling older men: relationships to age and bone loss. Journal of Bone and Mineral

Research 1999;14(1)S181. (Presented at American Society of Bone and Mineral Research.)

•Young investigator award, American Society of Bone and Mineral Research

52. Dachille M, Beyer T, Townsend DW, Hanwell LL, Jerin J, Meltzer CC, Charron M. Installation and

operation of a combined PET/CT scanner with a university medical center environment. J Nucl Med

Tech 1999(Presented at the Society of Nuclear Medicine for technologist 1999, Los Angeles)

53. Charron M, DiLorenzo C, Kocoshis S. Screening for IBD with SBFT studies and leukocyte

scintigraphy vs colonoscopy. Radiology 1999;213(P)526. (Presented at the Radiological Society of

North America 1999, Chicago)

54. Charron M, Beyer T, Kinahan P, Meltzer CC, Dachille MA, Townsend DW. Initial evaluation of

combined PET/CT scanning in oncology compared with PET only. Radiology 1999; 213(P)522.

(Presented at the Radiological Society of North America 1999, Chicago)

55. Webber SA, Pophal SA, Kiaffas MG, Fricker J, Harker K, Charron M, Miller SA, Law YM, Ellis D,

Pigula FA, Sutton R, Boyle GJ. Nephrotoxicity of cyclosporine versus tacrolimus immunosuppression in

pediatric heart transplantation. Circulation 1999; 100:(18)848

56. Danielson ME, Cauley JA, Charron M, Heaney RP. Is fractional calcium absorption related to

postmenopausal bone loss? Journal Of Bone And Mineral Research 1999; 14: SU357

Page 27: cv charron  2017

57. Charron M, DiLorenzo C, Kocoshis S. CT versus colonoscopy and WBC scintigraphy in the evaluation

of IBD. Pediatric Radiology syllabus. (Presented at the Society for Pediatric Radiology, Naples, FL,

May1-3, 2000)

58. Charron M, Kocoshis SA, Di Lorenzo C, Goyal A, Del Rosario F, Putnam P, Orenstein SR, Collins. Tc-

99m Antigranulocyte Monoclonal Antibody Imaging for the Detection of Newly Diagnosed

Inflammatory Bowel Disease by Colonoscopy in Children. Journal of Nuclear Medicine, 2000; 41(5).

53p (Presented at the Society of Nuclear Medicine 2000, St-Louis, May 2000)

59. Katyal S*, Charron M, Villemagne V, Dachille M, Townsend DW. The added value of a combined

PET/CT scanner compared with only CT imaging in patients with abdominal malignancies. European

Journal of Nuclear Medicine 2000;26….. (Presented at the European society of nuclear medicine Berlin.

Paris 2000)

60. Beyer T, Townsend D, Charron M, Kinahan P, Nutt R. Dual-modality PET/CT imaging for clinical

oncology using a single tomograph. German Society of Nuclear Medicine Meeting.

61. Charron M, Kocoshis SA, Di Lorenzo C, Goyal A, Del Rosario F, Putnam P, Orenstein SR, Collins L.

Assessment of Inflammatory Activity with Tc-99m Antigranulocyte Monoclonal Antibody in Children

Newly-Diagnosed by Colonoscopy to have Inflammatory Bowel Disease. Radiology 2000; 217(P)111.

(Presented at the Radiological Society of North America 2000, Chicago. Nov 26-dec 1, 2000)

62. Lacomis J, Costello P, Townsend DW, Feris, J, Kirkwood JM, Meltzer CC, Charron M, VilleMagne V,

Dachille M, Combined PET-CT Imaging for the Assessment of Metastatic Melanoma, Preliminary

Experience at the University of Pittsburgh. Radiology 2000; 217(P)636. Educational exhibit. (Presented

at the Radiological Society of North America 2000, Chicago. Nov 26-dec 1, 2000

63. Bai C*, Kinahan P, Brasse D, Comtat C, Townsend D, Meltzer CC, Villemagne V, Charron M. Effects

of Attenuation Correction on Tumor Detection in PET Oncology. IEEE MEETING Nuclear science

symposium.

64. Kang TI*, Brophy P, Hickeson M, Heyman S, Evans AE, Charron M, Maris JM. Non-myeloablative

doses of 131I-MIBG are effective for disease palliation in refractory neuroblastoma. 2001 Pediatric

Academic Societies Meeting. Journal of Pediatric Hematology/Oncology:23 A18 (#1184), 2001

Pediatric Research. [print] 49(4 Part 2). April, 2001. 209A.

65. Newberg A, Charron M, Alavi A. Characterization of brain death in order to help optimize organ

donation and help refine its diagnosis. Society for Neuroscience Abstracts. 27(1). 2001. 1481

66. Meltzer CC, Martinelli MA, Beyer T, Kinahan PE, Charron M, McCook B, Townsend DW. Whole-

Body Fdg Pet Imaging In The Abdomen: Value Of Combined Pet/Ct. Journal of Nuclear Medicine

2001;42(5) 35p. (Presented at the Society of Nuclear Medicine 2001, Toronto).

67. Charron M, Kocoshis SA, Di Lorenzo C, Villemagne V Assessment of the Inflammatory Activity of

Crohn's with WBC-TC99M and Laboratory Values. Radiology 2001; 221(P)127. (Presented at the

Radiological Society of North America 2001, Chicago. Nov 25-30, 2001)

68. Ghesani N*, Charron M, Zhuang HM, Park R, Villemagne V. Usefulness of Initial One Hour Dynamic

Disida Imaging in the Evaluation of Biliary Atresia in Infants Presenting with Hyperbilirubinemia.

Page 28: cv charron  2017

Journal of Nuclear Medicine 2001;42(5) 88p. (Presented at the Society of Nuclear Medicine 2001,

Toronto)

69. Hickeson M*, Charron M, Kang TA, Maris J. Biodistribution and Sensitivity of Therapeutic Versus

Diagnostic 131I-MIBG Scans in Children with Neuroblastoma. Journal of Nuclear Medicine 2001;42(5)

318p. (Presented at the Society of Nuclear Medicine 2001, Toronto)

70. Charron M, Di Lorenzo C, Kocoshis S, Villemagne V. Temporal Correlation of ESR with 99mTc-WBC

Uptake in Children with IBD. Journal of Nuclear Medicine 2001;42(5) 343p. (Presented at the Society of

Nuclear Medicine 2001, Toronto)

71. Ponzo F*, Charron M. Comparison of subjective evaluation of 99mTc-White Blood Cells (WBCs)

uptake and quantitative analysis in children with inflammatory bowel disease. (Presented at the Society

for Pediatric Radiology Annual Meeting, April 27 - May 1, 2002 Philadelphia, Pennsylvania) Pediatric

Radiology 2002; 32 (6) S77

72. Alberini JL*, Charron M, Ponzo F, Von Allmen D. Correlation of total intensity uptake in White Blood

Cells Scintigraphy and biological parameters in the follow-up of children with Inflammatory Bowel

Disease. (Presented at the Society for Pediatric Radiology Annual Meeting, April 27 - May 1, 2002

Philadelphia, Pennsylvania) Pediatric Radiology 2002; 32 (6) S63

73. Villemagne VL, Dlugos D, Ponzo F, Beauchemin D, Zaffino-Nevrotski T, Charron M. Effects Of

Attenuation Correction On Ictal And Interictal Brain SPECT Scans. (Presented at the Society for

Pediatric Radiology Annual Meeting, April 27 - May 1, 2002 Philadelphia, Pennsylvania). Pediatric

Radiology 2002; 32 (6) S74

74. Villemagne VL, Dlugos D, Ponzo F, Beauchemin D, Zaffino-Nevrotski T, Charron M. The Diagnostic

Value Of Crossed Cerebellar Diaschisis On Ictal And Interictal Brain SPECT In Children With

Refractory Epilepsy. Journal of Nuclear Medicine 2002;43(5) 346p (Presented at the Society for

Pediatric Radiology Annual Meeting, April 27 - May 1, 2002 Philadelphia, Pennsylvania) Pediatric

Radiology 2002; 32 (6) S73

75. Villemagne VL, Dlugos D, Ponzo F, Beauchemin D, Edwards K, Charron M. Sensitivity Of Ictal And

Interictal Brain SPECT For The Diagnosis Of Focal Epilepsy At CHOP. (Presented at the Society for

Pediatric Radiology Annual Meeting, April 27 - May 1, 2002 Philadelphia, Pennsylvania) Pediatric

Radiology 2002; 32 (6) S73

76. Poduri A. Villemagne V, Ponzo F, Beauchemin D, Zaffino-Nevrotski T, Charron, M, Dlugos D.

Crossed Cerebellar Diaschisis On Single-Photon Emission Computed Tomography May Predict Seizure

Laterality In Children With Refractory Epilepsy. Epilepsia. 43 Supplement 7:77, October 2002

77. Accorsi R, Charron M, Carr MC, Canning DA. "A Comparison of Different Background Subtraction

Methods in the Evaluation of Renal Split Function. (Presented at the Society for Pediatric Radiology

Annual Meeting, April 27 - May 1, 2002 Philadelphia, Pennsylvania) Pediatric Radiology 2002; 32 (6)

S78

78. Accorsi R, Charron M. "Use of Difference Images for the Identification of Flow Paths in Dynamic

Scintigraphy" (Presented at the Society for Pediatric Radiology Annual Meeting, April 27 - May 1,

2002 Philadelphia, Pennsylvania) Pediatric Radiology 2002; 32 (6) S78

Page 29: cv charron  2017

79. Accorsi R, Morowitz MJ, Charron M, Maris JM. "Pinhole Imaging of 131I-Metaiodobenzylguanidine

(MIBG) in a High-Risk Neuroblastoma Murine Model". (Presented at the Society for Pediatric

Radiology Annual Meeting, April 27 - May 1, 2002 Philadelphia, Pennsylvania) Pediatric Radiology

2002; 32 (6) S69

80. Accorsi R, Charron M, Lanza RC. "Coded Apertures in Nuclear Medicine: Imaging a 19mCi 57Co

Point Source in 1 Second with 1.7-mm Resolution" (Presented at the Society for Pediatric Radiology

Annual Meeting, April 27 - May 1, 2002 Philadelphia, Pennsylvania) Pediatric Radiology 2002; 32 (6)

S63

81. Accorsi R, Charron M, Lanza RC. Fast, high-resolution, low-dose planar scintigraphy with Coded

Apertures: potential and limits. Journal of Nuclear Medicine 2002;43(5) 224p. (Presented at the Society

of Nuclear Medicine 2002, los Angeles) Pediatric Radiology 2002; 32 (6) S74

82. Adam LE, Accorsi R, Charron M, Karp JS. A new implementation of the single scatter simulation

algorithm for 3D PET. Journal of Nuclear Medicine 2002;43(5) 57p (Presented at the Society of

Nuclear Medicine 2002, Los Angeles)

83. Bhargava P, Charron M. Why do a radiographic V.C.U.G for evaluation of U.T.I in girls? Journal of

Nuclear Medicine 2002. 43(5) 345p. (Presented at the Society of Nuclear Medicine 2002, Los Angeles)

84. Hickeson M, Charron M. Normal Extraction Fraction Values of Tc-99m Mercaptoacetyltriglycine in

Children" Journal of Nuclear Medicine 2002. 43(5) 344p. (Presented at the Society of Nuclear

Medicine 2002, Los Angeles)

85. Matthay K, Yanik G, Huberty J, Hawkins R, Hasegawa B, Veatch J, Hasenauer B, Price D, Villablanca

J, Charron M, Brophy P, Sisson J, Reynolds CP, Groshen S, Seeger R, Maris JM. 131I-MIBG with

myeloablastive chemotherapy and autologous stem cell transplant (ASCT) in refractory neuroblastoma:

a new approaches to neuroblastoma therapy (NANT) study. Advances in Neuroblastoma Research, June

17-19, 2002, Paris. ABSTRACTED in MPO

86. Matthay K, Maris JM, Weiss B, Huberty J, Price D, Glidden D, Veatch J, Brophy P, Hasegawa B,

Charron M, Hawkins R. Phase II study of high dose 131I-MIBG with hematopoietic stem cell transplant

in refractory neuroblastoma. Advances in Neuroblastoma Research, June 17-19, 2002, Paris.

ABSTRACTED in MPO

87. Alberini JL*, Charron M, Von Allmen D, Ponzo F. Evaluation of the temporal changes in the

distribution of bowel segments with inflammation in children with Crohn’s diseases. European Journal

of Nuclear Medicine and Molecular Imaging 2002. 29 (8) S 74. (Presented at the Annual congress of the

European association of nuclear medicine 2002, Vienna, Austria Aug 31- Sep 4, 2002)

88. Charron M, Khan J, Accorsi R, Hickeson M, Canning D. Supernormal Renal Function in Unilateral

Hydronephrotic Kidney. Radiology 2002; 225(p) 609. (Presented at the Radiological Society of North

America 2002, Chicago. Nov 30-dec 4, 2002)

89. Charron M, Alberini JL. Temporal Changes in the Distribution of Inflammation in Childen’s

Inflammatory Bowel Disease Using Leukocyte-labelled Scintigraphies. Radiology 2002: 225(p) 519

(Presented at the Radiological Society of North America 2002, Chicago. Nov 30 dec 3, 2002)

Page 30: cv charron  2017

90. Hoe FM*, Charron M, Moshang T. Recombinant Human TSH (rTSH) Stimulated Thyroglobulin (TG)

Levels and Diagnostic Iodine-131 Whole Body Scanning (WBS) in the Management of Children with

Thyroid Carcinoma. Pediatric Research. 53(4 Part 2). April 2003 2003. 143A

91. DuBois S, Messina J, Maris J, Huberty J, Glidden D, Veatch J, Brophy P, Charron M, Hawkins R,

Matthay K. Hematologic toxicity of high dose 131I-MIBG therapy for advanced neuroblastoma.

Proceedings of the 39th Annual Meeting of the American Society for Clinical Oncology, May 31-June

3, 2003, Chicago, IL

92. Bhargava P*, Charron M. Combined with an Ultrasound, Radionuclide VCUG Is Superior in the Initial

Evaulation of Girls with UTI. (Society for Pediatric Radiology Annual Meeting, May 7-10, 2003 in San

Francisco, California)

93. Hickeson M*, Charron M, Khan J, Zhuang HM, Beauchemin D, Anderson G, Canning D. Correlation

of the ERPF with the Extraction Fraction Values of Technecium-99m Mecaptoacetyltriglycine. Pediatric

Radiology 2003; 33. S115 (Society for Pediatric Radiology Annual Meeting, May 7-10, 2003 in San

Francisco, California)

94. Charron M, Rubin J, Hurh P. Inflammatory Bowel Disease Activity Assessment With Biological

Markers And 99mTc-Wbc Scintigraphy: Are There Different Trends In Ileitis Versus Colitis? J Nucl Med

2003: 44(5) S 352. (Presented at the Society of Nuclear Medicine June 2003, New Orleans)

95. Charron M, Ponzo F. Eosinophilic Colitis In Pediatric Patients: Assessment With Scintigraphy With 99mTc White Blood Cells. J Nucl Med 2003: 44(5) S 349. (Presented at the Society of Nuclear Medicine

June 2003, New Orleans)

96. Accorsi R, Charron M, Beauchemin D, Lanza RC. 1.7mm Resolution Coded Aperture Scintigraphy Of

Growth Plates In Children: First Results. J Nucl Med 2003: 44(5) S 347. (Presented at the Society of

Nuclear Medicine June 2003, New Orleans)

97. Chotipanich C*, Charron M, Rubin JT, Lin J. Clinical Follow Up Of Children With Low Differential

Function On Diuretic Renogram. J Nucl Med 2003: 44(5) S 351. (Presented at the Society of Nuclear

Medicine June 2003, New Orleans)

98. Charron M. Biological Markers in the assessment of IBD. Radiology 2003; 227(p) 686. (Presented at

the Radiological Society of North America, Chicago. Dec 4, 2003)

99. Lee B*, Charron M. An Evaluation of the Clinical Utility of Three Phase Bone Scintigraphy vs

Magnetic Resonance Imaging (MRI) in Diagnosing Osteomyetlis in the Pediatric Population. RSNA

Radiology 2003; 227(p) 466. (Presented at the Radiological Society of North America 2003, Chicago

Dec 1, 2003)

100. Bhargava P*, Charron M. Why do a radiographic VCUG for evaluation of TI in girls? Syllabus ARC

2004. p. 42. (Presented at the Annual meeting of the Society of Uroradiology Abdominal Radiology

Course 2004, Scottsdale, March 7-12, 2004)

101. Bal G*, Charron M, Kadrmas DJ, DiBella E. Evaluation Of A Fast Sampling Protocol For Dynamic

Renal Imaging. Abstract book on CD J Nucl Med 2004: 45(5) 42P. (Presented at the Annual meeting of

the Society of Nuclear Medicine June 2004, Philadelphia)

Page 31: cv charron  2017

* Young Investigator Nominee, Annual meeting SNM.

102. Charron M, Kocoshis SA. IBD imaging in 3D. Abstract book on CD J Nucl Med 2004: 45(5) 304P.

(Presented at the Annual meeting of the Society of Nuclear Medicine June 2004, Philadelphia)

103. Charron M. Laboratory values and 99mTc-Wbc for the assessment of the inflammatory activity of

Crohns’ Diseases. Abstract Abstract book on CD J Nucl Med 2004: 45(5) 305P. (Presented at the

Annual meeting of the Society of Nuclear Medicine June 2004, Philadelphia)

104. Charron M, Hickeson M. Increased Sensitivity of therapeutic versus diagnostic I131 MIBG Scans in

children with Neuroblastoma. Abstract book on CD J Nucl Med 2004: 45(5) 307P. (Presented at the

Annual meeting of the Society of Nuclear Medicine June 2004, Philadelphia)

105. Matthay KK, Huberty J, Hawkins R, Yanik G, Charron M, Groshen S, Seeger R, Shusterman S, Maris

JM. 131I-MIBG double infusion with autologous stem cell transplant (ASCT) for neuroblastoma: A

New Approaches To Neuroblastoma Therapy (NANT) study. Advances in Neuroblastoma Research,

June 16-18, 2004, Genoa, Italy

106. Tatalkar A, Pampaloni M, Charron M. Comparison of Radionuclide Salivagrams and Milk Scanning for

Detection of Pulmonary Aspiration. Radiology 2004; 227(p) 609. (Presented at the Radiological

Society of North America 2004, Chicago. Nov 30-dec 4, 2004)

107. Yu JQ, Zhuang H, Hernandez-Pampaloni M, Edwards K, Alavi A, Newberg A, Barrett J, Schall J,

Charron M, Mascarenhas MR. High Fat Content Meal affects Gastric Emptying and Small Bowel

Transit. J Nucl Med 2005: 46(5) 224P. (Presented at the Annual meeting of the Society of Nuclear

Medicine June 2005, Toronto)

108. Yu JQ, Hernandez-Pampaloni M, Zhuang H, Maris J, Charron M, Takalkar A, El-Haddad G, Dhurairaj

T, Newberg A, Alavi A. Comparison of I-123 Labeled MIBG Diagnostic Scan with Posttherapeutic I-

131 Scan in Patients with Neuroblastoma. J Nucl Med 2005: 46(5) 333P. (Presented at the Annual

meeting of the Society of Nuclear Medicine June 2005, Toronto)

109. Baskin KM, Hernandez-Pampaloni M, El-Haddad G, El-Haddad G, Alavi A, Charron M, Towbin RB.

PET-CT Fusion as an Alternative Guidance Modality in Image-Guided Biopsy. Pediatr Radiol 2006; 36

(S1):63. (Presented at The International Pediatric Radiology 5th Conjoint Meeting, May 2006, Montreal)

110. AK Coates, K Leung, E Louca, M Green, M Tservistas, M Keller, M Charron. Can vibrating membrane

nebulizers deliver tobramycin faster than jet nebulizers? Hospital for Sick Children, Toronto, Canada,

Pari Gmb, Munich Germany.

111. Baskin KM, Hernandez-Pampaloni M, El-Haddad G, El-Haddad G, Alavi A, Charron M, Towbin RB.

PET-CT Fusion as an Alternative Guidance Modality in Image-Guided Biopsy. Pediatr Radiol 2006; 36

(S1):63. (Presented at The International Pediatric Radiology 5th Conjoint Meeting, May 2006, Montreal)

112. J.L. Pippii Salle, Anthony Cook, Frank Papanikolaou, Darius Bagli, Walid Farhat, Martin Charron and

A.E. Khoury. Artifactual Elevation of Differential Renal Function measured by Nuclear Scintigraphy in

Large Hydronephrotic Kidneys. Journal of Urology, vol. 175, number 4, page 245, 2006 (American

Urological Association, Atlanta on Ma 20-25, 2006).

Page 32: cv charron  2017

113. Takalkar A, Charron M, Baskin K, Hardy O, Steinmuller LA, Stanley CA, Adzick NS. Role of

Intraoperative Otreotide Studies in Localization of Insulinomas in Pediatric Patients. Northeast

Regional Meeting of the Society of Nuclear Medicine, Groton, CT, October 27-29, 2006.

114. Charron M, Green M, Leung K, Louca E, Coates AL. Using 99mTc-DTPA to Measure Lung Deposition

from Delivery Systems with Very Different Delivery Times. Northeast Regional Meeting of the Society

of Nuclear Medicine, Groton, CT, October 27-29, 2006.

115. Charron M. Eosinophilic Colitis in Pediatric Patients: Assessment with Scintigraphy with 99mTe

White Blood Cells. Radiology 2006; 907(p) (Presented at the Radiological Society of North America

92nd Scientific Assembly and Annual Meeting, Chicago, IL, November 26-December 1, 2006)

116. Warrington JC, Charron M, Salle P; The utility and properties of the geometric mean in the assessment

of differential renal function in pediatric lasix renography . J Nucl Med 2007: 48(5) 120P. (Presented at

the Annual meeting of the Society of Nuclear Medicine June 2007, Washington, DC)

117. Ribeiro N, Charron M, Parshuram C, Green M. A novel technique to evaluate the precision of multiple

pump systems infusing into a single site. (Presented at the Annual meeting of the Society of Nuclear

Medicine June 2007, Washington, DC) J Nucl Med 2007: 48(5) 463333P

118. Shammas, A, Charron M. The Diagnostic Yield of Whole Body Radioiodine Scan after Thyroidectomy

Prior to Ablation Therapy in Children with Well-differentiated Thyroid Carcinoma . Radiology 2007; p.

593(p) (Presented at the Radiological Society of North America 93nd Scientific Assembly and Annual

Meeting, Chicago, IL, November 26-December 1, 2007)

119. Price E, Lim R, Shammas A, Charron M. 18F-FDG PET/CT in pediatric oncology: Early experience at

The Hospital for Sick Children J. NUCL. Med. 49: 275P-b. 2008 (Presented at the Annual meeting of

the Society of Nuclear Medicine June 2008, New Orleans, LA)

120. Shammas A, Charron M. FDG PET/CT in the evaluation of PTLD in children following solid organ

transplantation J. NUCL. Med. 49: 276P-b. 2008(Presented at the Annual meeting of the Society of

Nuclear Medicine June 2008, New Orleans, LA)

121. Kohli M. Charron M. Vertebral fracture assessment in the pediatric patient: How does lateral dual

absorptiometry (DXA) compare to digital radiography? J. NUCL. Med. 49: 277P-b. 2008(Presented at

the Annual meeting of the Society of Nuclear Medicine June 2008, New Orleans, LA)

122. Lim SH, Tyrell P , Benseler S, Silverman E. Bone mineral density already present in newly diagnosed

Juvenile SLE patientsACR (American College of Rheumatology annual meeting) in San Francisco this October. Ref

pending

123. Ward LM, Matzinger M, Alos N, Atkinson S, Clarson C, Couch R, Cummings E, Glorieux FH, Grant R,

Halton J, Lentle B, Nadel H, Rodd C, Siminoski K, Stephure D, Taback S, Shenouda N, Rauch F and

the Canadian STOPP Consortium (2008). Advanced Vertebral Compression at Diagnosis among

Children with Acute Lymphoblastic Leukemia. Oral presentation at the 30thAmerican Society for Bone

and Mineral Research Annual Meeting, Montréal, Quebec, September 2008. J Bone Mineral Res Vol 23:

WG 23, S508

124. Lily Siok Hoon Lim, Susa Benseler, Pascal Tyrrell, Martin Charron, Earl Silverman

Early Recognition Of Juvenile Systemic Lupus Erythematosus (Jsle) Patients At Risk For Poor Long

Page 33: cv charron  2017

Term Bone Outcome Annual European Congress of Rheumatology EULAR 2009, Copenhagen,

Denmark, 10 – 13 June 2009. . Ref pending

125. Amin R, Charron M, Grinblat L, Shammas A, Grasemann H, Ratjen F. Positron Emission Tomography-

Computed Tomography (PET/CT) to assess changes in airway inflammation in pediatric patients with

cystic fibrosis. (Oral presentation, American Thoracic Society Meeting May 2009

126. Charron M Amin R, and Ratjen, F. 18FDG-PET Imaging Findings In Pulmonary Exacerbation of Cystic

Fibrosis Before and After Treatment. J Nucl Med 2009: 50(5) 273P. (Presented at the Annual meeting

of the Society of Nuclear Medicine June 2009, Toronto, On

127. Mary-Ann Matzinger et al. Advanced Vertebral Compression at Diagnosis among Children with Acute

Lymphoblastic Leukemia. The Society for Pediatric Radiology 52nd Annual Meeting , Carlsbad,

California, April 21-25, 2009 127. Ref pending

128. Shammas A., Charron M. Salivary gland scintigraphy in children with post duct ligation for sialorrhea. J

Nucl Med 2009: 50(5) 269P. (Presented at the Annual meeting of the Society of Nuclear Medicine June

2009, Toronto, On.

129. Zheng J, Alle Douglass C. Vines , Serra, Charron M, Jaffray DA. Liposome Contrast Agent for CT-

based Detection and Localization of Neoplastic and Inflammatory Lesions in Rabbits: Validation with

FDG-PET and Histology. WMIC 2009

130. Matzinger, N. Shenouda, B. Lentle, Huber, Charron M , C. Coblentz, J. Dubois, R. Kloiber H. Nadel,

K. O’Brien, M. Reed, K Siminoski, K. Sparrow0, C. Weber, L. M. Ward. Prevalent Vertebral Fractures

among Children Initiating Glucocorticoid Therapy for the Treatment of Reumatic Disorders and the

Canadian STOPP Consortium. European Society of Paediatric Radiology (ESPR) meeting in Bordeaux,

France Ref pending

131. Amin R, Charron M, Grinblat L, Shammas A, Grasemann H, Ratjen F. Positron Emission Tomography-

Computed Tomography (PET/CT) to assess changes in airway inflammation in pediatric patients with

cystic fibrosis. (Abstract accepted for oral presentation at the European Respiratory Society Conference

September 2010).

132. Lsh Lim, Sm Benseler, Pn Tyrrell, M Charron, Ed Silverman Predictors Of Long-Term Trajectories Of

Bone Mineral Density Among Pediatric Systemic Lupus Erythematosus Patients 2011 Acr/Arhp

Pediatric Rheumatology Symposium (Prsym), To Be Held In Miami, Fl, June 2-5, 2011.

P RSYM Abstract Award Winner

133. Shammas A, Vali R., Wasserman J., Forte V., Campisi p., Charron M.. F18-FDG PET/CT imaging for

pre-operative detection of nodal disease in pediatric differentiated thyroid cancer. J. NUCL. Med. 2012,

53 (Suppl 1): 2195.

134. El Zein M, Vali R., Charron M. Comparison of pulmonary artery diameter and flow with phase

contrast MRI to quantitative scintigraphic ratio of lung perfusion in pediatric congenital cardiac

disorder. J. NUCL. Med. 2012, 53 (Suppl 1): 2210

Page 34: cv charron  2017

135. Shammas A., Doria A.S., Charron M, Amirabadi A., Zhong A., Moineddin R., Metser U Capability of

Detection of Early Soft Tissue Inflammatory Changes in Knees of a Blood-Induced Arthropathy Rabbit

Model, 6th Congress and Exhibition of the Joint Societies of Paediatric. London, England, May 2011.

ABSTRACTnb

136. Vali Reza, El Zein Mohamad, Charron Martin, Costantini Danny, Daneman Alan. Accuracy of

diagnostic imaging in follow up of paediatric differentiated thyroid cancer. J. NUCL. Med. 2012, 53

(Suppl 1): 2207

137. Vali Reza, El Zein Mohamad, Laxer Ronald, Charron Martin.The potential value of bone mineral

densitometry in chronic recurrent multifocal osteomyelitis. J. NUCL. Med. 2012, 53 (Suppl 1): 2211

138. Costantini Danny, Vali Reza, Chan Jeffrey, McQuattie Susan, Charron Martin. Dual time point FDG

PET/CT for the evaluation of paediatric tumors. J. NUCL. Med. 2012, 53 (Suppl 1): 153

139. Jatin kaicker, reza vali, amer shammas, martin charron Common Causes for Congenital

Hypothyroidism using Thyroid Scintigraphy: The Hospital for Sick Children Experience.

2nd World Congress on Thyroid Cancer , June 11-14, Toronto.

140. Vali, charron The Significance of 18F-FDG Uptake in Neck Lymph Nodes in Pediatric Patients without

Head and Neck Malignancy

141. The Choice of Pediatric Reference Database Changes Spine Bone Mineral Density Z-scores but Not the

Relationship with Prevalent Vertebral Fractures. ASBMR 2014 Annual Meeting, September 12-15,

2014 at the George R. Brown Convention Center in Houston, Texas,

142. A pilot study of FLT PET/CT in pediatric lymphoma patients with equivocal FDG PET/CT findings.

Society of Nuclear Medicine 2015 Control ID: 2206658

143. J. Hay1, B. Martin1, B. Wilson2, P.M. Miettunen3, J. L. Jaremko2, A. M. Huber4, K Houghton5, J.

Ho3, R. Grant6, D.B. Dix5, M. Charron6, R. Barr7, T. Blydt-Hansen5, L.M Ward8 and the Canadian

STOPP Consortium

144. Contrasting Bone Fragility at Diagnosis of Active and Inactive Children with Acute Lymphoblastic

Leukemia , PWP2015 meeting from 9-13 September in Utrecht, the Netherlands

145. Characteristics of Children with Fractures at Diagnosis of ALL: the Influence of Physical Activity….

146. Hay1, B. Martin1, B. Wilson2, P.M. Miettunen3, J. L. Jaremko2, A. M. Huber4, K. Houghton5, J. Ho3,

R. Grant6, D.B. Dix5, M. Charron6, R. Barr7, T. Blydt-Hansen5, J. Ma8, L.M Ward8 and the Canadian

STOPP Consortium9North American Society for Pediatric Exercise Medicine (NASPEM) conference in

Knoxville, Tennessee ( August 10-13, 2016

147. Not up to date

Educational Exhibit:

Page 35: cv charron  2017

1. Charron M, Hickeson M, Maris J, Kang T. Therapeutic Uses of 131I-MIBG in Children with

Neuroblastoma. Presented at the Radiological Society of North America 2001, Chicago. Nov 26-dec 1,

2001)

2. Levine DS, Charron M. Only for kids: Nuclear medicine studies unique to pediatrics – a mini teaching

atlas. Presented at the Radiological Society of North America 2005, Chicago. Nov 30-dec 4, 2005).

3. Shammas A, Charron M. Brown Adipose Tissue in Pediatric FDG PET/CT Imaging. Radiology 2007;

p. 942(p) (Presented at the Radiological Society of North America 93nd Scientific Assembly and

Annual Meeting, Chicago, IL, November 26-December 1, 2007)

Certificate of Merit Award, RSNA,

4. Shammas A, Charron M., Lim R. Pediatric FDG PET/CT Imaging Pitfall and Normal Variants.

Radiology 2007; p. 942(p) (Presented at the Radiological Society of North America 93nd Scientific

Assembly and Annual Meeting, Chicago, IL, November 26-December 1, 2007)

Certificate of Merit Award, RSNA,

5. Costantini DL, Vali R, Chan J, McQuattieS, Charron M. Imaging Cell Proliferation with FLT PET/CT

in Paediatric Patients with Hodgkin's Lymphoma. 98th Radiological Society of North America annual

meeting, November 25 -30, 2012, Chicago, Illinois (educational poster presentation).

Book Chapters, Editorials, Reviews

1. Charron M, Parker JA. Quantitative thallium imaging: Review Article. Critical reviews in diagnostic

imaging 1989;29(4)409-433

2. Glynn NW, Cauley J, Kuller L, Meilahn E, Charron M, Anderson S.. The determinants of bone mineral

density in older men, PH.D. Thesis, University of Pittsburgh, School of Public Health. June 1994

3. Charron M, Brown M. Primary and metastatic bone disease. Diagnostic Nuclear Medicine, Editors Martin

P. Sandler et al., Williams and Wilkins, 3rd edition. 1996; 1:649-668

4. Towbin R, Charron M, Meza M. Imaging in pediatric endocrinology. Sperling M (ed), Pediatric

Endocrinology, Saunders, 1996;20:549-577

5. Charron M. Assessment of inflammatory bowel diseases with 99mTc-HMPAO-WBC in pediatric patient.

Quarterly Journal of Nuclear Medicine 1997;41(4)309-320

6. Foley TF, Charron M. Radioiodine treatment of juvenile graves disease. Experimental and Clinical

Endocrinology & Diabetes 1997; 105(4)61-65

7. Wolf RL, Cauley JA, Baker C, Caggiula AW, Gregg EW, Charron M, Ferrell RE, Kuller LH. Calcium

absorption in pre-and perimenopausal women; Relationship to Vitamin D Receptor(VDR) gene status.

PHD Thesis. University of Pittsburgh, 1998

8. Charron M. The Technetium leukocyte scan in inflammatory bowel disease. Current Gastroenterology

Reports 1999;1(3)245-252

Page 36: cv charron  2017

9. Townsend DW, Beyer T, Kinahan PE, Charron M, Dachille M, Meltzer C, Brun T, Jerin J, Bryars LG, Nutt

R. Recent studies with a combined PET/CT scanner. Positron Emission Tomography in the Millennium.

Editors Tamaki N et al. Elsevier Science B.V. 2000. Amsterdam. p.229-245(ISBN 0-444-50385-5)

10. Charron M, Pediatric Inflammatory Bowel Disease Imaged with Tc-99m White Blood Cells, Clin Nucl

Med 2000; 25(9):708-715

11. Beyer T, Townsend DW, Nutt R, Charron M, Kinahan P, Meltzer CC. Combined PET/Ct imaging using a

single, dual-modality tomograph: a promising approach to clinical oncology of the future (chapter 10, pp.

101-124) in: PET in clinical oncology, edt.: Helmut J. Wieler and R. Edward Coleman. Steinkopff Verlag,

Darmstadt Springer, ISBN 3-7985-1219-1 2000

12. Pollock A, Towbin R, Charron M, Meza M. Imaging in Pediatric Endocrine disorders. P.725-57. In

Pediatric Endocrinology. Saunders, Philadelphia, 2002

13. Charron M, Brown M. Primary and metastatic bone disease. Diagnostic Nuclear Medicine, Editors Martin

P. Sandler et al., Williams and Wilkins, 4rd edition, 2003

14. Bruce Y. Lee, MD and Martin Charron. Chapter XX : Nuclear Cardiology and Positron Emission

Tomography by, MD to be published in a new textbook entitled Ventricular Function and Blood Flow in

Congenital Heart Disease. Editor Fogel, Springer Verlag January 2005

15. Foley TP Jr, Charron M, Linkov F, Krenzelok EP: "Radiation Terrorism", In: Pediatric Endocrinology: A

Clinical Guide, Lifshitz F, Ed., Marcel Dekker, Inc., New York, 5th ed, 2006

16. Martin Charron, The Biologic Effects of Low-Level Radiation, in Practical Pediatric Positron Emission

Tomography Imaging. Springer Verlag. 2006. 600 pages. ISBN 10:387-28836-8

17. Girish Bal, Stefaan Vandenberghe, and Martin Charron, Coincidence Imaging, Practical Pediatric Positron

Emission Tomography Imaging. Springer Verlag. 2006. 600 pages. ISBN 10:387-28836-8

18. Jian Qin Yu and Martin Charron, Other Tumors , Practical Pediatric Positron Emission Tomography

Imaging. Springer Verlag. 2006. 600 pages. ISBN 10:387-28836-8

19. Jean-Louis Alberini and Martin Charron. Inflammatory Bowel Disease, Practical Pediatric Positron

Emission Tomography Imaging. Springer Verlag. 2006. 600 pages. ISBN 10:387-28836-8

20. Fabio Ponzo and Martin Charron, Current Research Efforts . Practical Pediatric Positron Emission

Tomography Imaging. Springer Verlag. 2006. 600 pages. ISBN 10:387-28836-8

21. Peeyush Bhargava and Martin Charron, Common Artifacts on PET Imaging . Practical Pediatric

Positron Emission Tomography Imaging. Springer Verlag. 2006. 600 pages. ISBN 10:387-28836-8

22. Charron M. Application of PET/CT in Children. Paediatric Respiratory Reviews 2006; 75:541-543

23. Pediatric Renal Nuclear Medicine, Clinical Pediatric Urology, 5th Edition. 2007

24. Warrington JC, Charron M. Pediatric gastrointestinal nuclear medicine. Semin Nucl Med. 2007

Jul;37(4):269-85.

Page 37: cv charron  2017

25. Shammas A, Lim R, Charron M. CME: Pediatric FDG PET/CT: Physiologic Uptake,

Normal Variants, and Benign Conditions. Radiographics September 2009;29:1467-1486.

26. Hong TS, Shammas A, Charron M, Zukotynski KA, Drubach LA, Lim R. Brown adipose tissue

(18)F-FDG uptake in pediatric PET/CT imaging. Pediatr Radiol. 2011. 41(6). 759-768.

27. Shammas A, Vali R, Charron M. Pediatric nuclear medicine in acute care. Semin Nucl Med.

2013;43(2):139-56.

28. Charron, M. Contemporary approach to diagnosis and treatment of neuroblastoma. Q J Nucl Med Mol Imaging

2013 Mar;57(1):40-52.

29. Vali R, Charron M. Pediatric Nuclear Oncology. Chap 25. Cumali Aktolun, MD, MSc, and Stanley J. Goldsmith

MD. Nuclear Oncology. In Press

30. Vali R, Charron M. Nuclear Medicine in Pediatric gastrointestinal Tract. Walker’s Pediatric Gastrointestinal Disease: Physiology, Diagnosis, Management, 6thedition, Under publication.,

2015

31. Vali R, Charron M. Pediatric Renal Nuclear Medicine. Docimo, SG, Canning, DA, Khoury, AE (Supervising Editors), Austin, P, Coplen, D, Copp, H, Herndon, CDA, Lorenzo, A, Merguerian, P, Ost, M, Park, J, Shukla, A (Editors) : THE KELALIS-KING-BELMAN TEXTBOOK OF CLINICAL PEDIATRIC

UROLOGY, SIXTH EDITION

32. Reza Vali1, Lydia Bajno1, Mahnaz Kousha2 and Charron Martin3The Potential Role of Radionuclide Imaging

in Osteoporotic Vertebral Fracture and Sacral Fracture, iMedPub Journals. Vol. 1 No. 1: 11

PAST GRANT SUPPORT

Name of Grant Period of

Grant

Role in

Grant

% Effort Funding

Source

Annual

Direct Cost

1. Fracture in older

women: Study of

osteoporotic

3/92-1/01 CI

FG

5% NIH $1,796,595

2. Imaging of pediatric

inflammatory bowel

disease with a Tc-99

antigranulocyte

monoclonal antibody.

8/98-6/00 PI

IG-CT

10% Immunomedics

Inc

$65,000

3. The value of 11C-

Flumazenil in new onset

partial seizure

7/01-7/03 CI

CT

NA Foerderer Fund $66,000

4. Evaluation of dopamine

transporters in vivo in

children with ADHD

7/01- 6/03 CI NA Foerderer Fund $66,000

Page 38: cv charron  2017

5. Imaging of children

with Coded aperture

(#27025-232170503)

5/02-5/03 CI 10% ONDP and

MIT

$103,000

6. Design of new and

improvement of current

renal processing

software

11/2-11/03 PI

IG

1.5% Philips Inc. $ 7800

7. Depth correction

methodology for renal

studies

11/2-11/03 CI 1.5% Philips Inc. $ 20,800

8. Assesment of

efficiency, patient flow

and patient preference

for the Skylight

11/2-11/03 CI 1% Philips Inc. $ 3000

9. 131I-MIBG Escalating

Dose Rapid Sequence

Double Infusion

Followed by

Autologous Stem Cell

Infusion for Refractory

Neuroblastoma

1/03-1/04 CI 2.5% NIH-NANT ? 50,000

10.

Imaging of children

with Coded aperture

(#27025-232170503)

5/03-5/04

CI

5%

MIT and

ONDP

$127,073

11. Fighting children’s

Cancer Foundation.

12/04 PI $500.00

Current Collaborative Research Funding

Name of Grant Period of

Grant

Role in

Grant

% Effort Funding

Source

Budget

1. PET-CT phantoms

experiment

3/08-6/08 PMH

UHNPD05-026 1240$

2. Imaging cell proliferation

with FLT PET: A pilot

study in pediatric

lymphoma patients with

equivocal FDG PET

findings

07/11-07/12 CI RSNA:

RMS1102 3000$

Page 39: cv charron  2017

3. Uses of Ga68-DOTA-TOC

to identify focal lesions in

Children with congenital

hyperinsulinimia and/or

hyperinsulinemia.

08/11- PI CDPC ~~50,000

4. Evaluation of lymphoma

and other neoplasia with

PET

07/09- PI HSC

Foundation 100,000

5. FLT uptake in neoplasia

07/11-07/12 PI Garron

Foundation 48,000$

6.

Deep electrodes PET in

Adult Epilepsy

05/10

CI

UHN

? 20,000$

7.

A Collaborative Study of

Molecular Imaging

Biomarkers for Directing

the Optimal Therapy for

Pediatric

Neuroblastoma Patients

LOI

“accepted” 2011

Full grant

submitted

8/15/2011

CIHR

$2,308,417

8.PET DOTA neuroblastoma 1/13-1/14 Garron fondation

50,000

Funded by Radiology/HSC:

PET-FDG Oncology

PET-FDG Neurology eiplepsy

PET-FDG vs MEG

Collaborator:

Number Name PI Image requirements

NM 05 HMF Study

(Growth &

development in

preterm infants fed

human milk

containing a

powdered human

milk fortifier (HMF)

post hospital

discharge)

Dr. Deborah L O'Connor

(Clinical Dietetics)

DEXA - Total body fat composition

Page 40: cv charron  2017

NM 06 BMD in neonates

with bowel disease

Dr. Aideen Moore

(Neonatology)

DEXA - Total body fat composition

NM 17 STOPP-CIS

(Steroid-induced

osteoparosis in the

pediatric population -

Canadian incidence

study)

Dr. Ron Grant

(Haem/ Onc)

DEXA-Total Body fat composition,

L-spine & femur

(baseline study is clinical, the rest

research)

NM 19 CAMPS/2

(Childhood asthma

management program

study - phase 2 )

Dr. P.J. Subbarao

(originally Dr I.

MacLusky)

(Respiratory Medicine)

DEXA - L-spine

NM 29 A cross-sectional

study of overweight

in pediatric survivors

of ALL

Dr. Paul Nathan

(Haem/ Onc)

DEXA - Total body fat composition

MISC:

Publications quoted in American College of Radiology (ACR) Appropriateness Criteria:

PDF] ACR Practice Guideline for the Performance of Adult and Pediatric ...

... REFERENCES 1. Charron M, Brown ML. Primary and metastatic bone disease. In: Sandler MP, Coleman RE, Wackers FJ, et al, eds. Diagnostic Nuclear Medicine. ... www.acr.org/.../SecondaryMainMenuCategories/quality_safety/guidelines/nuc_med/skeletal_scintigraphy.aspx - Text Version

[PDF] [REV.] Practice Guideline for the Performance of Voiding ...

... 11. Hoberman A, Charron M, Hickey RW, Baskin M, Kearney DH, Wald ER. Imaging studies after a first febrile urinary tract infection in young children. ... www.acr.org/.../quality_safety/guidelines/dx/genit/voiding_cystourethrography.aspx - Text Version [ More results from www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines ]

[PDF] ACR Appropriateness Criteria Crohn’s Disease EVIDENCE TABLE

Page 1. ACR Appropriateness Criteria ® Crohn’s Disease EVIDENCE TABLE Reference Study Type Patients/ Events Study Objective (Purpose ... www.acr.org/acet/Crohns-Disease-ET.pdf - 2009-08-12 - Text Version

[PDF] RESOLUTION NO. 33 1 2 BE IT RESOLVED, 3 that the American College ...

... 329 11. Hoberman A, Charron M, Hickey RW, Baskin M, Kearney DH, Wald ER. Imaging 330 studies after a first febrile urinary tract infection in young children. ... www.acr.org/.../acr_meetings/amclc09/council/review-resolutions/ReferenceCommittee4/Resolution33.aspx - Text Version

[PDF] Urinary Tract Infection

Page 1. Date of origin: 1999 Last review date: 2008 ACR Appropriateness Criteria ® 1 Urinary Tract Infection — Child American ... www.acr.org/.../app_criteria/pdf/ExpertPanelonPediatricImaging/UrinaryTractInfectionChildDoc10.aspx - Text Version

[PDF] Imaging Recommendations for Patients with Crohn's Disease

Page 41: cv charron  2017

Page 1. Date of origin: 1998 Last review date: 2008 ACR Appropriateness Criteria ® 1 Crohn’s Disease American College of Radiology ... www.acr.org/.../app_criteria/pdf/ExpertPanelonGastrointestinalImaging/CrohnsDiseaseDoc5.aspx - Text Version

Alternative Media:

August 12, 1998 Press: Pittsburgh Post Gazette. Exposure to radiation in children.

1998- HTTP://www.pitt.edu/ charron

May 1999 TV: Television interview. PET/CT, Siemens

September,1999 Press release Siemens

December 29, 1999 Press: USA Today. PET/CT

December 1999 Interview, World On-Line News Radiology. Radiological Society of North

America

December 6, 1999 Interview, Arthur Pease, Siemens: July issue of New World magazine

1999-2/2000 WEB: Crohn’s Colitis Foundation of America, “Ask the specialist”

(www.ccfa.org/medcentral/specialist/)

10/22/2000 Interview by Mary Patouillet for “Advance for Radiologic Science professional”

2000. 13 (24): 42-43

1/11/2001 Interview, JNM news,

4/14/2001 Taiwan Video conference, Urology, CHOP

consultant for Amersham-Nycomed Inc,

Siemens Inc.

Philips Inc

University of Pittsburgh 2015-

2014- Member, Advisory Board, Start up company, Open Source Health Inc.